Announcements & Documents
Thesis Documents
Download File
Education
1980 - 1984
1980 - 1984Expertise In Medicine
Dokuz Eylul University, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Turkey
1973 - 1979
1973 - 1979Undergraduate
Ege University, Faculty Of Medicine, Turkey
Research Areas
Health Sciences
Academic Positions
1985 - 2024
1985 - 2024Professor
Dokuz Eylul University, Onkoloji Enstitüsü
Managerial Experience
2022 - 2024
2022 - 2024Dean
Dokuz Eylul University, Tıp Fakültesi
2012 - 2024
2012 - 2024Director of The Institution
Dokuz Eylul University, Onkoloji Enstitüsü
Supervised Theses
2024
2024Doctorate
Nöroblastom ve Hippo Sinyal Yolağı
Altun Z. S. (Co-Advisor), Olgun H. N.
S.KUM(Student)
2023
2023Doctorate
The effect of smac mimetics on apoptotic and necroptotic cell death mechanisms on neuroblastoma cells
OLGUN H. N. (Advisor)
B.BARAN(Student)
2022
2022Doctorate
Effect of hypoxia on tumor behavior in in vitro neuroblastoma model
OLGUN H. N. (Advisor)
S.BAYRAK(Student)
2022
2022Expertise In Medicine
Epidemiology and survival characteristics in childhood lymphomas and solid organ tumors treated at OUR center
OLGUN H. N. (Advisor)
B.ACUN(Student)
2021
2021Doctorate
Medulloblastomda moleküler belirteçler ve klinik ilişkisi
OLGUN H. N. (Advisor)
E.ATASEVEN(Student)
2021
2021Doctorate
The relationship of chemo-immunotherapy and graft materials used in bone cancers with the micro environment
OLGUN H. N. (Advisor)
Ö.BEKCİOĞLU(Student)
2019
2019Expertise In Medicine
Central nervous system embronic tumors and prognostic properties treated in our center
OLGUN H. N. (Advisor)
A.ÖKSEL(Student)
2017
2017Doctorate
The effects of oleuropein and cisplatin on neuroblastoma cells
OLGUN H. N. (Advisor)
D.DURSUN(Student)
2017
2017Doctorate
Microrna-17, microrna-19b, microrna-146A, microrna-302d expressions in hepatoblastoma and clinical importance
OLGUN H. N. (Advisor)
Ç.ÖMÜR(Student)
2016
2016Expertise In Medicine
Merkezimizde tedavi edilen çocukluk çağı kanserlerinde sağkalım oranları
OLGUN H. N. (Advisor)
A.SEZER(Student)
2015
2015Doctorate
Relationship between neuroblastoma and microRNA
OLGUN H. N. (Advisor)
K.ERGİN(Student)
2013
2013Postgraduate
Clinical significance of DNA repair genes expressions in neurofibromatosis TYPE 1 cases
OLGUN H. N. (Advisor)
D.DURSUN(Student)
2013
2013Doctorate
Effects of phytochemicals on neuroblastoma and metastatic potential
OLGUN H. N. (Advisor)
D.İNCE(Student)
2013
2013Post Doctorate of Medicine
The time to diagnosis in childhood lymphomas and malignant solid tumors
OLGUN H. N. (Advisor)
R.EMRE(Student)
2012
2012Post Doctorate of Medicine
Onkolojik tedavide sisplatin ve/veya karboplatin almış kanserli çocuk hastalarda ototoksisitenin değerlendirilmesi
OLGUN H. N. (Advisor)
D.İNCE(Student)
Journal articles indexed in SCI, SSCI, and AHCI
2024
2024Low Expression of CASP8 Could be a Prognostic Biomarker in Neuroblastoma Patients
Altun Z. S., Ceyhan M., Yuan H., Kızmazoğlu D., Aktaş S., Olgun N.
JOURNAL OF CHILD NEUROLOGY
, vol.39, no.11-12, pp.386-394, 2024 (SCI-Expanded)
2024
2024Potential diagnostic and prognostic biomarkers of pediatric Burkitt lymphoma identified through miRNA expression profiling.
Küçük C., Sönmez E. E., Hatipoğlu T., Yuan H., Hu X., Ceylan A., et al.
Pediatric research
, no.Advanced online, 2024 (SCI-Expanded)
2024
2024Investigation of YAP-1, OTX-2, and nestin protein expressions in neuroblastoma: a preliminary study
Kum Özşengezer S., ALTUN Z. S., Sanlav G., BARAN B., KIZMAZOĞLU D., AKTAŞ S., et al.
Annals of Clinical and Translational Neurology
, vol.11, no.8, pp.2153-2165, 2024 (SCI-Expanded)
2024
2024Infantile Hemangiomas of the Head and Neck: A Single-Center Experience.
Kizmazoglu D., Ince D., Olgun Y., Cecen E., Guleryuz H., Erdag T., et al.
Children (Basel, Switzerland)
, vol.11, no.3, 2024 (SCI-Expanded)
2024
2024Evaluation of the diagnostic and prognostic clinical values of circulating tumor DNA and cell-free DNA in pancreatic malignancies: a comprehensive meta-analysis
ARAYICI M. E., İnal A., BAŞBINAR Y., OLGUN H. N.
Frontiers in Oncology
, vol.14, 2024 (SCI-Expanded)
2024
2024S-100 and MATH-1 Protein Expressions Can Be Useful for the Prediction of Clinical Outcome in Neuroblastoma Patients.
Sanlav G., Baran B., Kum Özşengezer S., Kizmazoğlu D., Altun Z. S., Aktaş S., et al.
Journal of pediatric hematology/oncology
, vol.46, no.1, pp.21-28, 2024 (SCI-Expanded)
2024
2024Pediatric paravertebral tumors: analysis of 96 patients
Kızmazoğlu D., İnce D., Çeçen R. E., Kızmazoğlu C., Guleryuz H., Özer E., et al.
Child's Nervous System
, vol.40, no.1, pp.123-133, 2024 (SCI-Expanded)
2023
2023The effect of the closed intravenous catheter system on first insertion success, indwelling time, and complications in pediatric hematology and oncology patients: A randomized controlled study
ÖZALP GERÇEKER G., Yıldırım B. G., Önal A., ÖREN H., OLGUN H. N., BEKTAŞ M.
European Journal of Oncology Nursing
, vol.67, 2023 (SCI-Expanded)
2023
2023BRAF MUTATION EXISTING WITH RAS MUTATIONS IN NEUROBLASTOMA
Aktaş T. Ç., Erol A., Kızmazoğlu D., Aktaş S., Olgun H. N.
Turk J Biochem 2023
, vol.48, no.s2, pp.63-65, 2023 (SCI-Expanded)
2023
2023Identification of ALK Mutation in Neuroblastoma on the point of Molecular Heterogeneity
Aktaş T. Ç., Kızmazoğlu D., Aktaş S., Gökbayrak Ö. E., Serinan E., Erol A., et al.
TECHNOLOGY IN CANCER RESEARCH AND TREATMENT
, vol.22, pp.1-7, 2023 (SCI-Expanded)
2023
2023Comparing Tribbles Homolog 3 (TRIB3) Protein Expression Levels with Clinicopathological Characteristics and Survival Among Neuroblastoma Patients
Baran B., Sanlav G., Kizmazoglu D., Ozsengezer S. K., Aktas S., Altun Z., et al.
CLINICAL MEDICINE INSIGHTS: ONCOLOGY
, vol.17, pp.1-8, 2023 (SCI-Expanded)
2023
2023The association between birth weight and the risk of neuroblastoma: a meta-analysis of observational studies involving 4,361,141 participants.
Olgun H. N., Arayici M. E., Cecen R. E., Basbinar Y., Ellidokuz H.
American journal of cancer research
, vol.13, no.9, pp.3854-3863, 2023 (SCI-Expanded)
2023
2023The association between birth weight and the risk of neuroblastoma: a meta-analysis of observational studies involving 4,361,141 participants
Olgun H. N., Arayici M. E., Çeçen R. E., Başbınar Y., Ellidokuz H.
AMERICAN JOURNAL OF CANCER RESEARCH
, vol.13, no.9, pp.3854-3863, 2023 (SCI-Expanded)
2023
2023The association of miR-204 and mir-483 5p expression with clinicopathological features of Wilms tumor: Could this provide foresight?
Orgen Calli A., Issin G., Yilmaz I., Ince D., Tural E., Guzelis I., et al.
Japanese journal of clinical oncology
, 2023 (SCI-Expanded)
2023
2023Unraveling the Mystery: Next Generation Sequencing Sheds Light on Neuroblastoma Pathogenesis and Targeted Therapies
Aktas T., Kizmazoglu D., Aktas S., Erol A., Serinan E., Gokbayrak O., et al.
FRONTIERS IN BIOSCIENCE-LANDMARK
, vol.28, no.8, pp.171-180, 2023 (SCI-Expanded)
2023
2023Whole-exome sequencing reveals genetic variants in low-risk and high-risk neuroblastoma.
Altun Z. S., Yuan H., Baran B., Aktaş S., Esmeray Sönmez E., Küçük C., et al.
Gene
, vol.860, pp.147233, 2023 (SCI-Expanded)
2023
2023IMMUNE AND INFLAMATORYRESPONSE HETEROGENEITY IN NEUROBLASTOMA
Aktaş T. Ç., Kızmazoğlu D., Aktaş S., Serinan E. Ö., Çeçen R. E., İnce D., et al.
TURKISH JOURNAL OF BIOCHEMISTRY
, vol.47, no.s1, pp.25, 2023 (SCI-Expanded)
2023
2023Identification of <i>ALK</i> Mutation in Neuroblastoma on the Point of Molecular Heterogeneity
Aktas T. c., KIZMAZOĞLU D., AKTAŞ S., Gokbayrak O. E., Serinan E., Erol A., et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT
, vol.22, 2023 (SCI-Expanded)
2022
2022Dinutuximab beta plus conventional chemotherapy for relapsed/refractory high-risk neuroblastoma: A single-center experience
OLGUN H. N., ÇEÇEN R. E., İNCE D., KIZMAZOĞLU D., BAYSAL B., Onal A., et al.
Frontiers in Oncology
, vol.12, 2022 (SCI-Expanded)
2022
2022An Efficient and Quick Analytical Method for the Quantification of an Algal Alkaloid Caulerpin Showed In-Vitro Anticancer Activity against Colorectal Cancer
Mert-Ozupek N., ÇALIBAŞI KOÇAL G., OLGUN H. N., BAŞBINAR Y., ÇAVAŞ L., ELLİDOKUZ H.
MARINE DRUGS
, vol.20, no.12, 2022 (SCI-Expanded)
2022
2022In-silico molecular interactions among the secondary metabolites of Caulerpa spp. and colorectal cancer targets
Mert-Ozupek N., Çalıbaşı Koçal G., Olgun H. N., Başbınar Y., Çavaş L., Ellidokuz H.
FRONTIERS IN CHEMISTRY
, 2022 (SCI-Expanded)
2022
2022WILMS TUMOR: SINGLE CENTER EXPERIENCE
Cecen E., Kizmazoglu D., KARATAŞ E., Ince D., UMAY C., ULUSOY O., et al.
PEDIATRIC BLOOD & CANCER
, vol.69, 2022 (SCI-Expanded)
2022
2022Comparison of Cytotoxic and Ototoxic Effects of Lipoplatin and Cisplatin in Neuroblastoma In Vivo Tumor Model.
Evin Eskicioğlu H., Olgun Y., Aktaş T., Aktaş S., Kolatan H. E., Serinan E., et al.
JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY
, vol.18, no.5, pp.392-398, 2022 (SCI-Expanded)
2022
2022The effect of text message reminders on nausea, vomiting and quality of life in children with cancer receiving cisplatin.
Akdeniz Kudubes A., Bektas M., İnce D., Olgun N.
Journal of pediatric nursing
, vol.64, 2022 (SCI-Expanded)
2022
2022Expression Profile of Selected Antitumor Immune Response Genes in Pediatric Classic Hodgkin Lymphoma
Gul G., Ceyhan M., İNCE D., OLGUN H. N., ÖZER E.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
, vol.30, no.5, pp.358-365, 2022 (SCI-Expanded)
2022
2022Gene-Specific DNA Methylation Profiles in Pediatric Medulloblastomas
Kanit N., Yoca O. U., İnce D., Olgun N., Özer E.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
, vol.25, no.2, pp.82-90, 2022 (SCI-Expanded)
2022
2022PD-L1 and PD-L2 Mutations in Pediatric Hodgkin Lymphoma: Do They Have Any Prognostic Significance?
Gul G., İnce D., Olgun N., Özer E.
FETAL AND PEDIATRIC PATHOLOGY
, vol.41, no.1, pp.49-57, 2022 (SCI-Expanded)
2022
2022Expressions of MicroRNA of Mixed Cellularity Hodgkin Lymphomas are Different in Paediatric and Adult Patients
AKTAŞ S., Diniz G., Ceyhan M., Tosun-Yildirim H., Ceylan C., Oymak Y., et al.
WEST INDIAN MEDICAL JOURNAL
, vol.69, no.8, pp.565-570, 2022 (SCI-Expanded)
2021
2021High Grade Glioma of Central Nervous System: Single Center Treatment Experience
Ozdogar B., Ince D., Cecen R. E., Kizmazoglu C., Akyol S., Demiral A. N., et al.
PEDIATRIC BLOOD & CANCER
, vol.68, 2021 (SCI-Expanded)
2021
2021Dinutuxumab Beta Plus Conventional Chemotherapy for Relapsed/Refractory High-Risk Neuroblastoma: A Single Centre Experience
OLGUN H. N., Cecen R. E., Ince D., Onal A., Baysal B., Akyol S., et al.
PEDIATRIC BLOOD & CANCER
, vol.68, 2021 (SCI-Expanded)
2021
2021Management of The Infant Adrenal Mass Lesion: Single Center Experience
Olgun H. N., Mutafoglu K., Cecen R. E., Kizmazoglu D., Akyol S., Ulusoy O., et al.
PEDIATRIC BLOOD & CANCER
, vol.68, 2021 (SCI-Expanded)
2021
2021Treatment of Relapse/Refractory Neuroblastoma: Dokuz Eylul University Experience
Cecen R. E., Ince D., Kizmazoglu D., Akyol S., Ozdogan O., Ozer E., et al.
PEDIATRIC BLOOD & CANCER
, vol.68, 2021 (SCI-Expanded)
2021
2021Investigation of Molecular Sub-Groups by Immunohistochemical Methods and its Prognostic Importance in Medulloblastoma
Ataseven E., KANTAR M., AKTAŞ S., Erol A., Gokbayrak O., Ertan Y., et al.
PEDIATRIC BLOOD & CANCER
, vol.68, 2021 (SCI-Expanded)
2021
2021Management of Dinutuximab Beta Extravasation in Two Patients with Neuroblastoma
Cecen R. E., Ince D., Akyol S., Onal A., Ozler E., OLGUN H. N.
PEDIATRIC BLOOD & CANCER
, vol.68, 2021 (SCI-Expanded)
2021
2021Retinoblastoma: Experience from a Single Center in Turkey
Ince D., Cecen R. E., Akyol S., Yaman A., Ucar H., Demiral A. N., et al.
PEDIATRIC BLOOD & CANCER
, vol.68, 2021 (SCI-Expanded)
2021
2021Evaluation of Risk Factors Causing Ototoxicity in Childhood Cancers Located in the Head and Neck Region Treated With Platinum-based Chemotherapy.
Olgun Y., Cakir Kizmazoglu D., İnce D., Ellidokuz H., Güneri E. A., Olgun N., et al.
Journal of pediatric hematology/oncology
, vol.43, no.7, 2021 (SCI-Expanded)
2021
2021Bone marrow disease assessment in neuroblastoma: is it significant in patient management?
Ekmekci S., Ince D., Olgun N., Ozer E.
VIRCHOWS ARCHIV
, vol.479, no.SUPPL 1, 2021 (SCI-Expanded)
2021
2021High-grade glioma of central nervous system: Single center treatment experience.
Olgun N., Kizmazoglu D., Ozdogar B., Cecen E., Kizmazoglu C., Akyol S., et al.
JOURNAL OF CLINICAL ONCOLOGY
, vol.39, no.15, 2021 (SCI-Expanded)
2021
2021Safety of Eicosapentaenoic Acid in Cancer Treatment: Effect on Cancer Cells and Chemotherapy in Vitro
Aktaş S., Ercetin P., Altun Z. S., Kantar M., Olgun N.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
, vol.73, no.4, pp.568-571, 2021 (SCI-Expanded)
2021
2021The effect of virtual reality on pain, fear, and anxiety during access of a port with huber needle in pediatric hematology-oncology patients: Randomized controlled trial
Özalp Gerçeker G., Bektaş M., Aydınok Y., Ören H., Ellidokuz H., Olgun N.
EUROPEAN JOURNAL OF ONCOLOGY NURSING
, vol.50, 2021 (SCI-Expanded)
2021
2021Questioning How to Define the "Ultra-High-Risk" Subgroup of Neuroblastoma Patients.
Demir A. B., Aktas S., Altun Z. S., Ercetin P., Aktas T. C., Olgun N.
Folia biologica
, vol.67, no.1, pp.1-9, 2021 (SCI-Expanded)
2020
2020Determining the Effect of Retinoic Acid on PI3K/AKT and RAS/MAPK Pathways on Childhood Solid Tumors by using Western Blot
Gokbayrak O. E., Aktas S., Erol A., Altun Z. S., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.67, 2020 (SCI-Expanded)
2020
2020Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol Low Risk Group Treatment Results
Ince D., Kurucu N., Varan A., Akici F., Demirag B., Cecen E., et al.
PEDIATRIC BLOOD & CANCER
, vol.67, 2020 (SCI-Expanded)
2020
2020The Effect of Fucoidan and Cisplatin on DNA Damage Related Genes in Cochlear Cells
Tutuncu M., Ozsengezer S. K., Olgun Y., Altun Z. S., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.67, 2020 (SCI-Expanded)
2020
2020Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol High Risk Group Treatment Results
Ince D., Aksoylar S., Kurucu N., Varan A., Cecen E., Vergin C., et al.
PEDIATRIC BLOOD & CANCER
, vol.67, 2020 (SCI-Expanded)
2020
2020Evaluating ALK Mutations in Neuroblastoma With Next Generation Sequencing (On Behalf of Turkish Pediatric Oncology Group)
Aktas T., Yuan H., Gokbayrak O. E., Aktas S., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.67, 2020 (SCI-Expanded)
2020
2020Evaluating Molecular Heterogeneity in Neuroblastoma With Next Generation Sequencing (On behalf of Turkish Pediatric Oncology Group)
Aktas T., Yuan H., Gokbayrak O. E., Serinan E., Erol A., Aktas S., et al.
PEDIATRIC BLOOD & CANCER
, vol.67, 2020 (SCI-Expanded)
2020
2020Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol Intermediate Risk Group Treatment Results
Ince D., Kurucu N., Varan A., Akici F., Demirag B., Cecen E., et al.
PEDIATRIC BLOOD & CANCER
, vol.67, 2020 (SCI-Expanded)
2020
2020Childhood Cancers and Heredity: A Single Center Experience
Baysal B., Ince D., Kizmazoglu D., Akyol S., Demiral A. N., Guleryuz H., et al.
PEDIATRIC BLOOD & CANCER
, vol.67, 2020 (SCI-Expanded)
2020
2020MRI-based texture analysis for differentiating pediatric craniofacial rhabdomyosarcoma from infantile hemangioma
Sarioglu F. C., Sarioglu O., Güleryüz Uçar H., Özer E., İnce D., Olgun H. N.
EUROPEAN RADIOLOGY
, no.10, pp.5227-5236, 2020 (SCI-Expanded)
2020
2020Antioxidant effect of acetyl-l-carnitine against cisplatin-induced cardiotoxicity
Bayrak S., Aktaş S., Altun Z. S., Cakir Y., Tutuncu M., Ozsengezer S. K., et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
, vol.48, no.8, 2020 (SCI-Expanded)
2020
2020Cross-sectional study: long term follow-up care for pediatric cancer survivors in a developing country, Turkey: current status, challenges, and future perspectives
İncesoy Özdemir S., Taçyıldız N., Varan A., Kebudi R., Zulfikar B., Celkan T., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.50, no.8, pp.1916-1921, 2020 (SCI-Expanded)
2019
2019Experience of Pediatric Tuberous Sclerosis Complex
İnce D., Baysal B., Kucukali T., Kizmazoglu D., Akyol S., Cecen E., et al.
PEDIATRIC BLOOD & CANCER
, vol.66, 2019 (SCI-Expanded)
2019
2019BRAF V600E Mutation: A Significant Biomarker for Prediction of Disease Relapse in Pediatric Langerhans Cell Histiocytosis
Özer E., Sevinc A., İnce D., Yuzuguldu R., Olgun N.
PEDIATRIC AND DEVELOPMENTAL PATHOLOGY
, vol.22, no.5, pp.449-455, 2019 (SCI-Expanded)
2019
2019PD-L1 and PD-L2 mutations in paediatric Hodgkin Lymphoma: do they have any prognostic significance?
Gul G., İnce D., Olgun N., Ozer E.
VIRCHOWS ARCHIV
, vol.475, 2019 (SCI-Expanded)
2019
2019BRAF V600E mutation: a significant biomarker for prediction of disease in paediatric Langerhans cell histiocytosis
Ozer E., Sevinc A., İnce D., Yuzuguldu R., Olgun N.
VIRCHOWS ARCHIV
, vol.475, 2019 (SCI-Expanded)
2018
2018Treatment of Stage 4S Neuroblastoma: Dokuz Eylul University Experience of the Last 10 Years
İnce D., Kizmazoglu D., Baysal B., Cecen E., Ozer E., Aktas S., et al.
PEDIATRIC BLOOD & CANCER
, vol.65, 2018 (SCI-Expanded)
2018
2018Mesenchimal Stem Cell and Cisplatin Interference in Neuroblastoma Experimental Animal Model
Aktas S., Ercetin P., Aydin M., Calisir M., Bekcioglu O., Yilmaz O., et al.
PEDIATRIC BLOOD & CANCER
, vol.65, 2018 (SCI-Expanded)
2018
2018Treatment of Children with Intermediate-Risk Neuroblastoma: Dokuz Eylul University Experience
İnce D., Erdem M., Kizmazoglu D., Cecen E., Aktas S., Altun Z. S., et al.
PEDIATRIC BLOOD & CANCER
, vol.65, 2018 (SCI-Expanded)
2018
2018Localized Neuroblastoma: The 30 Years Experience of Dokuz Eylul University
İNCE D., Kizmazoglu D., Cecen E., Erdem M., ALTUN Z. S., Aktas S., et al.
PEDIATRIC BLOOD & CANCER
, vol.65, 2018 (SCI-Expanded)
2018
2018Artificial Intelligence Methods for Risk Assessment of Neuroblastoma
Leblebici A., Uncu B., Onan A., BAŞBINAR Y., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.65, 2018 (SCI-Expanded)
2018
2018Could the Unidentified Bright Objects in Children be Accepted as an Additional Diagnostic Criterion for Neurofibromatosis Type-1?
İnce D., Erdem M., Kizmazoglu D., Sarioglu F. C., Ozdogar M. B., Baysal B., et al.
PEDIATRIC BLOOD & CANCER
, vol.65, 2018 (SCI-Expanded)
2018
2018Central Nervous System Metastases in Neuroblastoma: Results of Turkish Pediatric Oncology Group Neuroblastoma 2009 (TPOG-NB-2009) Protocol
Cecen E., İNCE D., SEVİNİR B. B., Cakir F. B., Kurucu N., Guler E., et al.
PEDIATRIC BLOOD & CANCER
, vol.65, 2018 (SCI-Expanded)
2018
2018The Effects of Cisplatin and Oleuropein on Neuroblastoma Cells
Dursun D., ALTUN Z. S., Aktas S., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.65, 2018 (SCI-Expanded)
2018
2018Evaluation of Ototoxicity in Children with Head and Neck Cancer who Received Cisplatin and/or Carboplatin During Treatment
Olgun Y., İNCE D., Kizmazoglu D., Erdem M., Kirkim G., Demiral A. N., et al.
PEDIATRIC BLOOD & CANCER
, vol.65, 2018 (SCI-Expanded)
2018
2018Dokuz Eylul University Pediatric Oncology Group: Ewing Sarcoma Family of Tumors Experience
İnce D., Kizmazoglu D., Erdem M., Cecen E., Baysal B., Cetingoz R., et al.
PEDIATRIC BLOOD & CANCER
, vol.65, 2018 (SCI-Expanded)
2018
2018A 3 Year Review of a Cohort Turkish Paediatric Oncology Group (TURKPEDPGx)
Başbınar Y., Uncu B., Leblebici A., Kocal G., Citak C., Ak E., et al.
PEDIATRIC BLOOD & CANCER
, 2018 (SCI-Expanded)
2018
2018MicroRNA profiles in neuroblastoma: Differences in risk and histology groups
ERGİN K., AKTAŞ S., ALTUN Z. S., Diniz G., Olgun N.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY
, vol.14, no.5, 2018 (SCI-Expanded)
2018
2018Comparison of Cisplatin with Lipoplatin in Terms of Ototoxicity
Serinan E., Altun Z. S., AKTAŞ S., Cecen E., Olgun N.
JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY
, vol.14, no.2, pp.211-215, 2018 (SCI-Expanded)
2017
2017The effects of disodium pentaborate decahydrate on in-vivo neuroblastoma animal model
ALTUN Z. S., Serinan E. O., AKTAŞ S., Calisir M., Aydin M., YILMAZ O., et al.
CLINICAL & EXPERIMENTAL METASTASIS
, vol.34, no.8, pp.495, 2017 (SCI-Expanded)
2017
2017In Vivo Prevention Local Effect of Cadmium of Local Recurrence in Xenograft Model of Osteosarcoma
Demirkiran D., Aktas S., Ercetin P., KOLATAN H. E., Yilmaz O., Havitcioglu H., et al.
PEDIATRIC BLOOD & CANCER
, vol.64, 2017 (SCI-Expanded)
2017
2017Treatment Results in Pediatric Head and Neck Rhabdomyosarcomas: A Single Center Experience
Mutafoglu K., İNCE D., Kizmazoglu D., Olgun Y., Erdem M., Demiral A. N., et al.
PEDIATRIC BLOOD & CANCER
, vol.64, 2017 (SCI-Expanded)
2017
2017Dokuz Eylul University Treatment Experience of Neuroblastoma
İNCE D., Kizmazoglu D., Cecen R. E., Erdem M., Aktas S., Serinan E., et al.
PEDIATRIC BLOOD & CANCER
, vol.64, 2017 (SCI-Expanded)
2017
2017Head and Neck Hemangiomas of Childhood: A Single Center Experience
Kizmazoglu D., İNCE D., Agrali N., Erkoc E., Erdem M., Erdag T., et al.
PEDIATRIC BLOOD & CANCER
, vol.64, 2017 (SCI-Expanded)
2017
2017The Effects of Rosiglitazone on Minimal Residual Disease Model of Neuroblastoma
ALTUN Z. S., Ayla M., Aktas S., Pamukoglu A., Ercetin P., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.64, 2017 (SCI-Expanded)
2017
2017Treatment of Relapse Neuroblastoma: Dokuz Eylul University Experience
İNCE D., Erdem M., Cecen R. E., Kizmazoglu D., Ozer E., Demiral A. N., et al.
PEDIATRIC BLOOD & CANCER
, vol.64, 2017 (SCI-Expanded)
2017
2017The Relation of Microenvironment Associated Gene Expression with Risk Classification in Neuroblastoma
Aktas S., Ercetin P., Serinan E., Aydin M., Altun Z. S., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.64, 2017 (SCI-Expanded)
2017
2017Retrospective Analysis of Our Patients with Pons Glioma
İNCE D., Kizmazoglu D., Erdem M., Demiral A. N., Cetingoz R., Guleryuz H., et al.
PEDIATRIC BLOOD & CANCER
, vol.64, 2017 (SCI-Expanded)
2017
2017Evaluation of Musculoskeletal Complaints and Skeletal Involvements in Children with Newly Diagnosed Lymphoma and Solid Tumors
İNCE D., Erdem M., Yenigurbuz F., Kizmazoglu D., Ataseven E., Guleryuz H., et al.
PEDIATRIC BLOOD & CANCER
, vol.64, 2017 (SCI-Expanded)
2017
2017Child with RET proto-oncogene codon 634 mutation
İNCE D., Demirag B., Ataseven E., Oymak Y., Tuhan H., Karakus O. Z., et al.
TURKISH JOURNAL OF PEDIATRICS
, vol.59, no.5, pp.590-593, 2017 (SCI-Expanded)
2017
2017Effect of mesenchymal stem cells, tumour infiltrating lymphocytes and cancer stem cells in the neuroblastoma
Ekin Z. Y., Aktas S., Altun Z. S., Serinan E., Ercetin P., Ekin R. G., et al.
VIRCHOWS ARCHIV
, vol.471, 2017 (SCI-Expanded)
2017
2017Treatment of high-risk neuroblastoma: National protocol results of the Turkish Pediatric Oncology Group
AKSOYLAR S., VARAN A., Vergin C., Hazar V., Akici F., Dagdemir A., et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, vol.13, no.2, pp.284-290, 2017 (SCI-Expanded)
2017
2017Intratubular large cell hyalinizing Sertoli cell tumor of the testis presenting with prepubertal gynecomastia: a case report
Tuhan H., ABACI A., SARSIK KUMBARACI B., Ozturk T., OLGUNER M., Catli G., et al.
ACTA CLINICA BELGICA
, vol.72, no.4, pp.254-258, 2017 (SCI-Expanded)
2016
2016Assessment of the Clinical Importance of Molecular Basis of Neuroblastoma: A Proteomic Approach (on behalf of Turkish Paediatric Oncology Group)
Demir A. B., ALTUN Z. S., Aktas S., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.63, 2016 (SCI-Expanded)
2016
2016Analysis of genetic and non genetic risk factors for cisplatin ototoxicity in pediatric patients.
OLGUN Y., AKTAŞ S., ALTUN Z. S., KIRKIM G., Kizmazoglu D., ERÇETİN A. P., et al.
International journal of pediatric otorhinolaryngology
, vol.90, pp.64-69, 2016 (SCI-Expanded)
2016
2016Effect of Mesenchymal Stem Cells and Tumour Infiltrating Lymphocytes on Cancer Stem Cells in Neuroblastoma (on behalf of Turkish Paediatric Oncology Group)
Yildirim Z., Aktas S., Ercetin P., ALTUN Z. S., Serinan E., Demir A. B., et al.
PEDIATRIC BLOOD & CANCER
, vol.63, 2016 (SCI-Expanded)
2016
2016Oncomir miR17, Tumour Suppressor miR146a, miR302d, and Oncogene miR19B Expressions in Hepatoblastoma Patients
Ecevit C. O., Aktas S., Yildirim H. T., Demirag B., Erbay A., Karaca I., et al.
PEDIATRIC BLOOD & CANCER
, vol.63, 2016 (SCI-Expanded)
2016
2016A Single Center Experience of a Treatment for Medulloblastoma
İNCE D., Mutafoglu K., Kizmazoglu D., Kizmazoglu C., ÇETİNAYAK H. O., Erdem M., et al.
PEDIATRIC BLOOD & CANCER
, vol.63, 2016 (SCI-Expanded)
2016
2016Comparison of Cisplatin with Lipoplatin in Terms of Ototoxicity
Serinan E., ALTUN Z. S., Aktas S., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.63, 2016 (SCI-Expanded)
2016
2016Clinically Importance of Prognostic Genetic Markers in Neuroblastoma (on behalf of Turkish Paediatric Oncology Group)
Ceyhan M., ALTUN Z. S., Demir A. B., Aktas S., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.63, 2016 (SCI-Expanded)
2016
2016Can High Risk Group be Categorized as "High Risk" and "Ultra-High Risk" in Neuroblastoma?(on behalf of Turkish Society of Paediatric Oncology Group)
Demir A. B., Aktas S., ALTUN Z. S., Ercetin P., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.63, 2016 (SCI-Expanded)
2016
2016prospective,observational nationwide study on pharmacogenomics/genetics of chilhood cancars incohort of turkish pediatric oncology group (TURKPEDPGX)
Başbınar Y., Çeçen R. E., Kızmazoğlu D., Çıtak E. Ç., Öniz H., Çalıbaşı Koçal G., et al.
Pediatric Blood & Cancer , vol.63, pp.154, 2016 (SCI-Expanded)
2016
2016Protective Effect of Acetyl-L-Carnitine Against Doxorubicin-induced Cardiotoxicity in Wistar Albino Rats
Dundar H. A., KİRAY M., KIR M., KOLATAN H. E., BAĞRIYANIK H. A., ALTUN Z. S., et al.
ARCHIVES OF MEDICAL RESEARCH
, vol.47, no.7, pp.506-514, 2016 (SCI-Expanded)
2016
2016Hepatopathy-Thrombocytopenia Syndrome During Actinomycin D Treatment May Be Related to MDR1 (ABCB1) Gene Polymorphisms
Başbınar Y., Amirfallah A., Çalıbaşı Koçal G., Olgun N.
AMERICAN JOURNAL OF THERAPEUTICS
, vol.23, no.2, 2016 (SCI-Expanded)
2016
2016The Detection of Genetic Parameters for Prognostic Stratification of Neuroblastoma Using Multiplex Ligation-Dependent Probe Amplification Technique
Tumer S., ALTUNGÖZ O., Bagci O., OLGUN H. N.
GENETIC TESTING AND MOLECULAR BIOMARKERS
, vol.20, no.2, pp.74-80, 2016 (SCI-Expanded)
2016
2016Intratubular Large Cell Hyalinizing Sertoli Cell Tumor of the Testis Presenting with Prepubertal Gynecomastia: A Case Report
Tuhan H., ABACI A., SARSIK KUMBARACI B., Ozturk T., OLGUNER M., Catli G., et al.
HORMONE RESEARCH IN PAEDIATRICS
, vol.86, pp.272-273, 2016 (SCI-Expanded)
2016
2016Acetyl-L-Carnitine protects HEI-OC1 auditory cells from radiation and cisplatin induced toxicity
ALTUN Z. S., Pamukoglu A., OLGUN Y., AKTAŞ S., ÇETİNAYAK H. O., KIRKIM G., et al.
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
, vol.9, no.7, pp.13605-13614, 2016 (SCI-Expanded)
2015
2015RHABDOMYOSARCOMA EXPERIENCE: A SINGLE INSTITUTION'S RESULTS
Mutafoglu K., İnce D., Kizmazoglu D., Erdem M., Ataseven E., Yenigurbuz F., et al.
PEDIATRIC BLOOD & CANCER
, vol.62, 2015 (SCI-Expanded)
2015
2015MIFAMURTIDE (L-MTP-PE) IN CHILDREN WITH OSTEOSARCOMA: THE TURKISH EXPERIENCE
Kebudi R., Sari N., KANTAR M., Cakir F. B., Guler E., Olgun N., et al.
PEDIATRIC BLOOD & CANCER
, vol.62, 2015 (SCI-Expanded)
2015
2015TREATMENT RESULTS OF PEDIATRIC GERM CELL TUMORS FROM A SINGLE INSTITUTION
İNCE D., Mutafoglu K., Yenigurbuz F., Ataseven E., Kizmazoglu D., Erdem M., et al.
PEDIATRIC BLOOD & CANCER
, vol.62, 2015 (SCI-Expanded)
2015
2015Expressions of microRNA of mix cellularity Hodgkin lymphomas are different in pediatric and adult
Diniz G., Aktas S., Ceyhan M., Yildirim H. T., Ceylan C., Oymak Y., et al.
VIRCHOWS ARCHIV
, vol.467, 2015 (SCI-Expanded)
2015
2015Apoptotic Effects of Sanguinarine on the Organ of Corti 1 Cells: Comparison with Cisplatin
Cecen E., Ercetin P., KIRKIM G., Pamukoğlu A., AKTAŞ S., ALTUN Z. S., et al.
JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY
, vol.11, no.1, pp.19-22, 2015 (SCI-Expanded)
2014
2014CHILDREN WITH RET PROTOONCOGENE CODON 634 MUTATION
İNCE D., Kadioglu B., Buke E., Oymak Y., Unver H., Karakus O. Z., et al.
PEDIATRIC BLOOD & CANCER
, vol.61, 2014 (SCI-Expanded)
2014
2014HEPATOBLASTOMA: CLINICAL CHARACTERISTICS AND OUTCOME OF 13 PATIENTS
İNCE D., Mutafoglu K., Buke E., Yenigurbuz F., Kilic M., OLGUNER M., et al.
PEDIATRIC BLOOD & CANCER
, vol.61, 2014 (SCI-Expanded)
2014
2014LANGERHANS CELL HISTIOCYTOSIS: A SINGLE CENTER EXPERIENCE
Mutafoglu K., İNCE D., Buke E., Kizmazoglu D., Yenigurbuz F., Ozer E., et al.
PEDIATRIC BLOOD & CANCER
, vol.61, 2014 (SCI-Expanded)
2014
2014IN VIVO EFFECT OF SANGUINARINE ON NEUROBLASTOMA
Cecen E., Aktas S., Pamukoglu A., KOLATAN H. E., Ercetin P., Demir B., et al.
PEDIATRIC BLOOD & CANCER
, vol.61, 2014 (SCI-Expanded)
2014
2014MIFAMURTIDE (L-MTP-PE) IN CHILDREN WITH OSTEOSARCOMA: THE TURKISH EXPERIENCE
Kebudi R., Ilhan I., KANTAR M., Cakir F. B., Guler E., Olgun N., et al.
PEDIATRIC BLOOD & CANCER
, vol.61, 2014 (SCI-Expanded)
2014
2014ACETYL L CARNITINE INTERFERES WITH ANTITUMOR EFFECT OF CISPLATIN
Aktas S., ALTUN Z. S., Pamukoglu A., KOLATAN H. E., Ercetin P., Dursun D., et al.
PEDIATRIC BLOOD & CANCER
, vol.61, 2014 (SCI-Expanded)
2014
2014MOLECULAR PROFILE OF NEUROBLASTOMA IN TURKEY ON BEHALF OF THE TURKISH SOCIETY OF PEDIATRIC ONCOLOGY
Aktas S., Demir B., Ercetin P., ALTUN Z. S., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.61, 2014 (SCI-Expanded)
2014
2014POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: EXPERIENCE OF THREE PATIENTS
Olgun N., Mutafoglu K., İNCE D., Buke E., Kizmazoglu D., Kilic M., et al.
PEDIATRIC BLOOD & CANCER
, vol.61, 2014 (SCI-Expanded)
2014
2014Determination of the effects of job satisfaction and empathy levels of oncology nurses on patient satisfaction
Ates S., Baran A., Celikbilek F., Dincer Z. M., Olgun N.
EUROPEAN JOURNAL OF ONCOLOGY NURSING
, vol.18, 2014 (SCI-Expanded)
2014
2014Expression profiling of microRNAs in neuroblastoma tumors in different stages and histology
Ergin K., Aktas S., ALTUN Z. S., Diniz G., Olgun N.
EUROPEAN JOURNAL OF CANCER
, vol.50, 2014 (SCI-Expanded)
2014
2014Protective effect of acetyl-l-carnitine against cisplatin ototoxicity: role of apoptosis-related genes and pro-inflammatory cytokines.
ALTUN Z. S., Olgun Y., Ercetin P., Aktas S., Kirkim G., Serbetcioglu B., et al.
Cell proliferation
, vol.47, no.1, pp.72-80, 2014 (SCI-Expanded)
2014
2014Promoting Effects of Sanguinarine on Apoptotic Gene Expression in Human Neuroblastoma Cells
Cecen E., ALTUN Z. S., Ercetin P., AKTAŞ S., Olgun N.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, vol.15, no.21, pp.9445-9451, 2014 (SCI-Expanded)
2013
2013EVALUATION OF OTOTOXICITY IN CHILDREN WITH CANCER WHO RECEIVED CISPLATIN AND/OR CARBOPLATIN DURING TREATMENT
İNCE D., Mutafoglu K., Kirkim G., Olgun Y., Buke E., Serbetcioglu B., et al.
PEDIATRIC BLOOD & CANCER
, vol.60, pp.160-161, 2013 (SCI-Expanded)
2013
2013ACETYL-L-CARNITINE HAS PROTECTIVE EFFECTS AGAINST EXPERIMENTAL DOXORUBICIN CARDIOTOXICITY
Adiguzel H., ALTUN Z. S., KOLATAN H. E., Aktas S., Kiray M., Yilmaz O., et al.
PEDIATRIC BLOOD & CANCER
, vol.60, pp.157, 2013 (SCI-Expanded)
2013
2013CLINICAL SIGNIFICANCE OF DNA REPAIR GENES EXPRESSIONS IN NEUROFIBROMATOSIS TYPE 1 CASES
Dursun D., Aktas S., Ercetin P., ALTUN Z. S., İNCE D., Mutafoglu K., et al.
PEDIATRIC BLOOD & CANCER
, vol.60, pp.19, 2013 (SCI-Expanded)
2013
2013Tissue Expression of MLH1, PMS2, MSH2, and MSH6 Proteins and Prognostic Value of Microsatellite Instability in Wilms Tumor: Experience of 45 Cases
Diniz G., AKTAŞ S., Cubuk C., Ortac R., Vergin C., Olgun N.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.30, no.4, pp.273-284, 2013 (SCI-Expanded)
2013
2013A CASE OF RAPID-ONSET OBESITY WITH HYPOTHALAMIC DYSFUNCTION, HYPOVENTILATION, AUTONOMIC DYSREGULATION, AND NEURAL CREST TUMOR: ROHHADNET SYNDROME
ABACI A., Catli G., Bayram E., Koroglu T., OLGUN H. N., Mutafoglu K., et al.
ENDOCRINE PRACTICE
, vol.19, no.1, 2013 (SCI-Expanded)
2012
2012THE EFFECT OF RESVERATROL ON ARA-C INDUCED CEREBELLAR TOXICITY
Orel B., Mutafoglu K., CİLAKER MIÇILI S., BAĞRIYANIK H. A., KİRAY M., ALTUN Z. S., et al.
PEDIATRIC BLOOD & CANCER
, vol.59, no.6, pp.1093, 2012 (SCI-Expanded)
2012
2012POLYMORPHİSMS CHARACTERİSTİCS OF ENZYMES ( CYP2C9, CYP2C8, ALDH1A, ALDH3A1) IN CYCLOPHOSPHAMIDE METABOLİC PATHWAY
Amirfallah A., Çalıbaşı Koçal G., Ellidokuz H., Olgun N., Başbınar Y.
Turkish Journal Of Biochemistry-Türk Biyokimya Dergisi , vol.37, no.S1, pp.14, 2012 (SCI-Expanded)
2012
2012Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors
Bagci O., Tumer S., Olgun N., Altungöz O.
CANCER LETTERS
, vol.317, no.1, pp.72-77, 2012 (SCI-Expanded)
2012
2012Effect of Retinoic Acid and Chemotherapeutic Agents on Untrastructural Localization of Myc-N in Neuroblastoma
AKTAŞ S., ALTUN Z. S., ÖZOĞUL C., Olgun N.
JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
, vol.29, no.3, pp.588-593, 2012 (SCI-Expanded)
2012
2012The role of p14ARF methylation in neuroblastoma minimal residual disease
Erbayraktar Z., Zadeoglulari Z., AKTAŞ S., ELLİDOKUZ H., Kirkali G., Olgun N.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
, vol.37, no.2, pp.129-138, 2012 (SCI-Expanded)
2011
2011Soft tissue sarcomas and central nervous system tumors in children with neurofibromatosis type 1.
Cecen E., İNCE D., Uysal K. M., ÖZER E., Cetingoz R., Ozguven A. A., et al.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
, vol.27, no.11, pp.1885-93, 2011 (SCI-Expanded)
2011
2011EFFECT OF PHYTOCHEMICALS ON NEUROBLASTOMA AND METASTATIC POTENTIAL
İNCE D., AKTAŞ S., ALTUN Z. S., Cubuk C., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.57, no.5, pp.781, 2011 (SCI-Expanded)
2011
2011MICROSATELLITE INSTABILITY IN WILMS TUMOR
Diniz G., AKTAŞ S., Cubuk C., Ortac R., Vergin C., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.57, no.5, pp.783, 2011 (SCI-Expanded)
2011
2011THE TURKISH PEDIATRIC ONCOLOGY GROUP NEUROBLASTOMA 2003 (TPOG-NBL-2003) PROTOCOL: FACTORS THAT EFFECT SURVIVAL RATES
İNCE D., Aksoylar S., Varan A., Vergin C., Hazar V., Sevinir B., et al.
PEDIATRIC BLOOD & CANCER
, vol.57, no.5, pp.795, 2011 (SCI-Expanded)
2011
2011TUMOR METASTASIS GENES IN NEUROBLASTOMA STEM CELLS
AKTAŞ S., Ercetin P., ALTUN Z. S., Cubuk C., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.57, no.5, pp.782-783, 2011 (SCI-Expanded)
2011
2011Role of Survivin in Determination of Chemoresistance in Neuroblastoma
Erbayraktar Z., AKTAŞ S., ALTUN Z. S., Olgun N.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, vol.31, no.5, pp.1087-1093, 2011 (SCI-Expanded)
2011
2011Coexisting of Wilms Tumor and Ganglioneuroblastoma in a Child
Cecen E., Olgun N., Mutafoglu K., OLGUNER M., İNCE D., ÖZER E.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.28, no.7, pp.619-621, 2011 (SCI-Expanded)
2011
2011The Time to Diagnosis in Childhood Lymphomas and Other Solid Tumors
Cecen E., Gunes D., Mutafoglu K., SARIALİOĞLU F., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.57, no.3, pp.392-397, 2011 (SCI-Expanded)
2011
2011A 7-year-old Girl with Cough, Fever, Pneumonia
Firinci F., ATEŞ O., KARAMAN Ö., Tekin A., ÖZER E., Cakmakci H., et al.
PEDIATRIC ANNALS
, vol.40, no.3, pp.124-127, 2011 (SCI-Expanded)
2011
2011Hypersensitivity to Procarbazine and Severe RSV Pneumonia in a Child with Hodgkin's Lymphoma
İNCE D., Olmez D., Koroglu T. F., Hocaoglu A. B., Camlar S. A., Uysal K. M., et al.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, vol.21, no.3, pp.183-187, 2011 (SCI-Expanded)
2011
2011Evaluation of the Effect of Acetyl L-Carnitine on Experimental Cisplatin Ototoxicity and Neurotoxicity
Gunes D., KIRKIM G., KOLATAN H. E., GÜNERİ E. A., ÖZOĞUL C., ALTUN Z. S., et al.
CHEMOTHERAPY
, vol.57, no.3, pp.186-194, 2011 (SCI-Expanded)
2010
2010KOREAN RED GINSENG: A CANDIDATE PROTECTIVE AGENT FOR CISPLATIN NEPHROTOXICITY BUT NOT MYELOTOXICITY
ALTUN Z. S., AKTAŞ S., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.55, no.5, pp.931, 2010 (SCI-Expanded)
2010
2010THE TURKISH PEDIATRIC ONCOLOGY GROUP NEUROBLASTOMA 2003 (TPOG-NBL-2003):TREATMENT RESULTS OF THE INFANTS
Gunes D., Aksoylar S., Buyukpamukcu M., Varan A., Hazar V., Vergin C., et al.
PEDIATRIC BLOOD & CANCER
, vol.55, no.5, pp.890, 2010 (SCI-Expanded)
2010
2010EFFECT OF RETINOIC ACID AND CHEMOTHERAPEUTIC AGENTS ON ULTRASTRUCTURAL LOCALIZATION OF MYC-N IN NEUROBLASTOMA
AKTAŞ S., ALTUN Z. S., ÖZOĞUL C., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.55, no.5, pp.893, 2010 (SCI-Expanded)
2010
2010ALLICIN INCREASES METASTASIS RELATED GENES IN NEUROBLASTOMA
Gunes D., Aktas S., ALTUN Z. S., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.55, no.5, pp.895, 2010 (SCI-Expanded)
2010
2010The Effect of Differentiating and Apoptotic Agents on Notch Signalling Pathway in Hepatoblastoma
AKTAŞ S., Zadeoglulari Z., Ercetin P., Olgun N.
HEPATO-GASTROENTEROLOGY
, vol.57, no.101, pp.891-898, 2010 (SCI-Expanded)
2010
2010Effect of Retinoic Acid and Cytotoxic Agent Combinations on Cell Cycle Proteins Cyclin D1 and P21 in Neuroblastoma
AKTAŞ S., ALTUN Z. S., Erbayraktar Z., Olgun N.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, vol.30, no.3, pp.947-951, 2010 (SCI-Expanded)
2010
2010TREATMENT OF WILMS TUMOR: A Report from the Turkish Pediatric Oncology Group (TPOG)
Akyuz C., YALÇIN B., Yildiz I., Hazar V., Yoruk A., Tokuc G., et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.27, no.3, pp.161-178, 2010 (SCI-Expanded)
2010
2010Successful Use of Inhaled Steroids For the Management of Radiation Pneumonitis in an Infant: Case Repot
Uysal K. M., UZUNER N., Cetingoz R., Ozguven A. A., Babayigit A., Olmez D., et al.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, vol.30, no.2, pp.808-811, 2010 (SCI-Expanded)
2010
2010Protective Effects of Acetyl-l-Carnitine on Cisplatin Cytotoxicity and Oxidative Stress in Neuroblastoma
ALTUN Z. S., Gunes D., AKTAŞ S., Erbayrktar Z., Olgun N.
NEUROCHEMICAL RESEARCH
, vol.35, no.3, pp.437-443, 2010 (SCI-Expanded)
2010
2010Expression and Methylation Pattern of p16 in Neuroblastoma Tumorigenesis
AKTAŞ S., Celebiler A. C., Zadeoglulari Z., Diniz G., Kargi A., Olgun N.
PATHOLOGY & ONCOLOGY RESEARCH
, vol.16, no.1, pp.1-6, 2010 (SCI-Expanded)
2010
2010Febrile neutropenic episodes in children with lymphoma and malignant solid tumors
Güneş D., Mutafoǧlu K., Çetinkaya H., Arslan H., Çakir D., Olgun N.
Cocuk Enfeksiyon Dergisi
, vol.4, no.1, pp.1-8, 2010 (SCI-Expanded)
2010
2010Effect of Cytotoxic Agents and Retinoic Acid on Myc-N Protein Expression in Neuroblastoma
AKTAŞ S., ALTUN Z. S., Erbayraktar Z., Aygun N., Olgun N.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
, vol.18, no.1, pp.86-89, 2010 (SCI-Expanded)
2009
2009Reply
Güneş D., Olgun N.
Turkish Journal of Pediatrics
, vol.51, no.4, pp.405-406, 2009 (SCI-Expanded)
2009
2009PLATINUM INDUCED OTOTOXICITY IN CHILDREN AND ADOLESCENTS WITH CANCER
Gunes D., KIRKIM G., Demiral P., Uysal K. M., Serbetcioglu B., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.53, no.5, pp.855-856, 2009 (SCI-Expanded)
2009
2009Hemangiomas of Childhood: Analysis of 116 Cases
Gunes D., Cecen E., Ozguven A. A., Kocaoglu S., Kenan Y., Gul S., et al.
TURKIYE KLINIKLERI TIP BILIMLERI DERGISI
, vol.29, no.5, pp.1137-1148, 2009 (SCI-Expanded)
2009
2009Prognostic Significance of Cell Proliferation and Apoptosis-Regulating Proteins in Epstein-Barr Virus Positive and Negative Pediatric Non-Hodgkin's Lymphoma
AKTAŞ S., Kargi A., Olgun N., Diniz G., Erbay A., Vergin C.
PATHOLOGY & ONCOLOGY RESEARCH
, vol.15, no.3, pp.345-350, 2009 (SCI-Expanded)
2009
2009The incidence of congenital malformations in children with cancer
Mutafoglu-Uysal K., Gunes D., TÜFEKÇİ Ö., Kalelihan-Cankal A., Sarialioglu F., Olgun N.
TURKISH JOURNAL OF PEDIATRICS
, vol.51, no.5, pp.444-452, 2009 (SCI-Expanded)
2009
2009Unilateral juvenile (virginal) hypertrophy of the breast Reply
Gunes D., Olgun N.
TURKISH JOURNAL OF PEDIATRICS
, vol.51, no.4, pp.405-406, 2009 (SCI-Expanded)
2009
2009Delayed Renal Excretion of Methotrexate After a Severe Anaphylactic Reaction to Methotrexate in a Child With Osteosarcoma
Ozguven A. A., Uysal K., Gunes D., Koroglu T., Gurcu O., Olgun N.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
, vol.31, no.4, pp.289-291, 2009 (SCI-Expanded)
2009
2009Paravertebral malignant tumors of childhood: analysis of 28 pediatric patients
Gunes D., Uysal K. M., Cetinkaya H., Tekin H. G., Yuceer N., SARIALİOĞLU F., et al.
CHILDS NERVOUS SYSTEM
, vol.25, no.1, pp.63-69, 2009 (SCI-Expanded)
2009
2009Platinum-Induced Ototoxicity in Children and Adolescents with Cancer
Gunes D., KIRKIM G., Demiral P., Uysal K. M., Serbetcioglu B., Olgun N.
JOURNAL OF INTERNATIONAL ADVANCED OTOLOGY
, vol.5, no.3, pp.345-355, 2009 (SCI-Expanded)
2009
2009Evaluation of the Effect of Acetyl L-Carnitine on Experimental Cisplatin Nephrotoxicity
TÜFEKÇİ Ö., Gunes D., Ozogul C., KOLATAN H. E., ALTUN Z. S., YILMAZ O., et al.
CHEMOTHERAPY
, vol.55, no.6, pp.451-459, 2009 (SCI-Expanded)
2009
2009Aneurysmal bone cyst of rib presenting as a huge chest wall mass.
Guenes D., Mutafoglu-Uysal K., Sanalioglu F., Cakmakci H., Olgun N.
The Turkish journal of pediatrics
, vol.51, no.1, pp.82-5, 2009 (SCI-Expanded)
2008
2008Unilateral juvenile (virginal) hypertrophy of the breast.
Guenes D., Mutafoglu-Uysal K., Canda T., Saydam S., Cemeroglu A. P., Olgun N.
The Turkish journal of pediatrics
, vol.50, no.3, pp.278-81, 2008 (SCI-Expanded)
2008
2008Pilomatricoma in children: A frequently misdiagnosed superficial tumor
Cecen E., Ozguven A. A., Uysal K. M., Gunes D., ÖZER E., Olgun N., et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.25, no.6, pp.522-527, 2008 (SCI-Expanded)
2008
2008STROMAL-PREDOMINANT MESENCHYMAL HAMARTOMA OF THE LIVER WITH ELEVATED SERUM ALPHA-FETOPROTEIN LEVEL
Gunes D., Uysal K. M., Cecen E., Cakmakci H., ÖZER E., Akgur F. M., et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.25, no.7, pp.685-692, 2008 (SCI-Expanded)
2007
2007Prognostic significance of cell proliferation and apoptosis-regulating proteins in Epstein-Barr virus positive and negative pediatric Hodgkin lymphoma
Aktaş S., Kargi A., Olgun N., Diniz G., Erbay A., Vergin C.
Lymphatic Research and Biology
, vol.5, no.3, pp.175-181, 2007 (SCI-Expanded)
2007
2007The incidence of congenital malformations in children with cancer
Uysal K. M., Gunes D., Tufekci Ö., Cankal A. K., Sarialioglu F., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.49, no.4, pp.480, 2007 (SCI-Expanded)
2007
2007Treatment results of pediatric germ cell tumors from a single institution
Uvsal K. M., Gunes D., Olgun N., Cecen E., Ozguven A. A., Olguner M., et al.
PEDIATRIC BLOOD & CANCER
, vol.49, no.4, pp.471-472, 2007 (SCI-Expanded)
2007
2007Association of MYCN amplification and 1p deletion in neuroblastomas with high tumor vascularity
Ozer E., Altungoz O., Unlu M., Aygun N., Tumer S., Olgun N.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
, vol.15, no.2, pp.181-186, 2007 (SCI-Expanded)
2007
2007An intermediary analysis of the Neuroblastoma Treatment Protocol-2003 of the Turkish Pediatric Oncology Group (TPOG) at October 2006
Olgun N.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
, vol.29, 2007 (SCI-Expanded)
2007
2007Veno-occlusive disease in a child with rhabdomyosarcoma after conventional chemotherapy: Report of a case and review of the literature
Cecen E., Uysal K. M., Ozguven A., Gunes D., Irken G., Olgun N.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.24, no.5-8, pp.615-621, 2007 (SCI-Expanded)
2007
2007Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma
Altungoz O., Aygun N., Tumer S., Ozer E., Olgun N., Sakizli M.
CANCER GENETICS AND CYTOGENETICS
, vol.172, no.2, pp.113-119, 2007 (SCI-Expanded)
2006
2006Evaluation of plasma tissue factor and tissue factor pathway inhibitor levels in childhood hemangiomas
Turker M., Irken G., Oren H., Yilmaz S., Yuksel F., Olgun N.
PEDIATRIC BLOOD & CANCER
, vol.47, no.7, pp.914-917, 2006 (SCI-Expanded)
2006
2006Antiproliferative and newly attributed apoptotic activities from an invasive marine alga: Caulerpa racemosa var. cylindracea
Çavaş L., Başbınar Y., Yurdakoç M. K., Olgun N.
JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY
, vol.339, no.1, pp.111-119, 2006 (SCI-Expanded)
2005
2005Inflammatory myofibroblastic tumor of the ileocecal mesentery mimicking abdominal lymphoma in childhood: Report of two cases
Corapcioglu F., Kargi A., Olgun N., Ozer E., OLGUNER M., Sarialioglu F.
SURGERY TODAY
, vol.35, no.8, pp.687-691, 2005 (SCI-Expanded)
2005
2005Effects of non toxic doses of acyclovir on nitric oxide and cellular death responses in herpesvirus types 1 and 2 infected HEp-2 cells
Baskin H., Yazici Z., BAŞBINAR Y., Olgun N., ÖZKUL A., Hakki Bahar I.
NEW MICROBIOLOGICA
, vol.28, no.3, pp.205-213, 2005 (SCI-Expanded)
2005
2005effects of acyclovir on nitric oxide and cell death in herpesvirus type 1 and type 2 infected HEp-2 cells
Baskın H., Yazıcı Z., Başbınar Y., Olgun N., Özkul A., Bahar H.
Clinical Microbiology And Infection , vol.11, no.s2, pp.1538, 2005 (SCI-Expanded)
2005
2005Selective apoptotic behaviour of bovine herpesvirus 1 in an epithelial-like microenvironment
Baskin Y., Yazici Z., Baskin H., Ozkul A., Olgun N., Bahar I.
ACTA VETERINARIA HUNGARICA
, vol.53, no.4, pp.479-491, 2005 (SCI-Expanded)
2004
2004Analysis of 136 febrile neutropenic episodes in children with cancer: Evaluation of treatment effectiveness and cost
Corapcioglu F., Sarialioglu F., Olgun N., Uysal K.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.21, no.6, pp.535-543, 2004 (SCI-Expanded)
2004
2004inversely proportional relation between programmed cell death and nitric oxide responses intencity behaviour of bovine herpesvirus 1 in epithelial like microenvironment
Başbınar Y., Yazıcı Z., Baskın H., Gecer O., Olgun N., Özkul A., et al.
Clinical Microbiology And Infection , vol.10, no.s3, pp.847, 2004 (SCI-Expanded)
2004
2004Prognostic significance of anaplasia and angiogenesis in childhood medulloblastoma: a pediatric oncology group study.
Ozer E., Sarialioglu F., Cetingoz R., Yuceer N., Cakmakci H., Ozkal S., et al.
Pathology, research and practice
, vol.200, no.7-8, pp.501-9, 2004 (SCI-Expanded)
2003
2003depending on the microenvironment nitric oxide may switch to another way of cell death in cervical carcinoma cell lines treated with staurosporin
Başbınar Y., Baskın H., Olgun N., Bahar H.
European Journal Of Cancer , vol.1, no.5, pp.619, 2003 (SCI-Expanded)
2003
2003Surveillance imaging and cost effectivity in pediatric brain tumors
Kovanlikaya A., KARABAY N., Cakmakci H., Uysal K., Olgun N., ERGÖR G.
EUROPEAN JOURNAL OF RADIOLOGY
, vol.47, no.3, pp.188-192, 2003 (SCI-Expanded)
2003
2003MLL-AF4 gene rearrangement in a child with Epstein-Baff virus-related posttransplant B-cell lymphoma
Corapcioglu F., Olgun N., Sarialioglu F., Uysal K., Oren H., Sercan O.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
, vol.25, no.9, pp.740-742, 2003 (SCI-Expanded)
2003
2003Experience of the Izmir pediatric oncology group on neuroblastoma: IPOG-NBL-92 protocol
Olgun N., Kansoy S., Aksoylar S., Cetingul N., Vergin C., Oniz H., et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.20, no.3, pp.211-218, 2003 (SCI-Expanded)
2002
2002Malignant pleural mesothelioma in a child: long-term survival with ICE-WAC chemotherapy regimen
Mutafoglu-Uysal K., Kargi A., Sarialioglu F., Olgun N., Kovanlikaya A.
TURKISH JOURNAL OF PEDIATRICS
, vol.44, no.3, pp.244-247, 2002 (SCI-Expanded)
2002
2002Assessment of peripheral lymphadenopathies: Experience at a pediatric Hematology-Oncology department in Turkey
Kumral A., Olgun N., Uysal K., Corapcioglu F., Oren H., Sarialioglu F.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.19, no.4, pp.211-218, 2002 (SCI-Expanded)
2001
2001High-dose oral methylprednisolone therapy in childhood hemangiomas
Uysal K., Olgun N., Erbay A., Sarialioglu F.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.18, no.5, pp.335-341, 2001 (SCI-Expanded)
2001
2001Bleomycin-induced hyperpigmentation and hypersensitivity reactions to etoposide and vinblastine in a child with endodermal sinus tumor
Mutafoglu-Uysal K., Sarialioglu F., Olgun N.
TURKISH JOURNAL OF PEDIATRICS
, vol.43, no.2, pp.172-174, 2001 (SCI-Expanded)
2001
2001A rare tumor of craniofacial bones in children: A pediatric chondroblastic osteosarcoma case with diagnostic and therapeutic problems
Uysal K., KOYUNCUOĞLU ÜLGÜN M., Akman F., Guneri A., Sarialioglu F., Kargi A., et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.18, no.2, pp.147-152, 2001 (SCI-Expanded)
2000
2000A case with extraosseous Ewing's sarcoma: A late effect related to bone marrow transplantation for thalassemia or a component of a familial cancer syndrome?
Uysal K., Olgun N., Sarialioglu F., Kargi A., Cevik N.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.17, no.5, pp.415-419, 2000 (SCI-Expanded)
2000
2000MR imaging of pancreatic metastasis from extraosseous Ewing's sarcoma
BARLIK OBUZ F., Kovanlikaya A., Olgun N., Sarialioglu F., Ozer E.
PANCREAS
, vol.20, no.1, pp.102-104, 2000 (SCI-Expanded)
1999
1999Tropisetron in the prevention of chemotherapy-induced acute emesis in pediatric patients
Uysal K., Olgun N., Sanalioglu F.
TURKISH JOURNAL OF PEDIATRICS
, vol.41, no.2, pp.207-218, 1999 (SCI-Expanded)
1998
1998Platelet activation during the early neonatal period
Irken G., Uysal K., Olgun N., Undar B., Akkoc N., ÖZKAN H., et al.
BIOLOGY OF THE NEONATE
, vol.73, no.3, pp.166-171, 1998 (SCI-Expanded)
1997
1997Posterior fossa pseudotumour due to viral encephalitis in a child
Unsal E., Olgun N., Sarialioglu F., Cevik N.
PEDIATRIC RADIOLOGY
, no.10, pp.788-789, 1997 (SCI-Expanded)
1997
1997Platelet activation in congenital heart diseases
Olgun N., Uysal K., Irken G., Unal N., Undar B., Akkoc N., et al.
ACTA PAEDIATRICA JAPONICA
, vol.39, no.5, pp.566-569, 1997 (SCI-Expanded)
1997
1997Multidisciplinary approach to thoracic extraosseous Ewing’xxs sarcoma
OTO Ö., HAZAN E., OKUTAN H., OLGUN N., UYSAL K., KARGI A. E., et al.
Journal Of Buon , no.3, pp.269-272, 1997 (SCI-Expanded)
1997
1997Çocuklukta malign plevral mezotelyoma ve olgu sunumu
AÇIKEL Ü., SARIOSMANOĞLU O. N., SİLİSTRELİ E. E., KARGI A. E., OLGUN N., OTO Ö.
Turk Gogus Kalp Damar Cerrahisi Dergisi-Turkish Journal Of Thoracic And Cardiovascular Surgery , 1997 (SCI-Expanded)
1996
1996Hyperglycemia and acute parotitis related to L-Asparaginase therapy
Uysal K., Uguz A., Olgun N., Sarialioglu F., Buyukgebiz A.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
, vol.9, no.6, pp.627-629, 1996 (SCI-Expanded)
1995
1995RELATIONSHIP BETWEEN SERUM UNCONJUGATED BILIRUBIN LEVELS AND THE AUTOFLUORESCENCE OF WHITE BLOOD-CELLS IN NEONATAL JAUNDICE
ÖZKAN H., AKKOC N., AYDIN A., KAVUKCU S., OLGUN N., IRKEN G., et al.
BIOLOGY OF THE NEONATE
, vol.68, no.2, pp.100-103, 1995 (SCI-Expanded)
1995
1995Atypical hemolytic uremic syndrome
KAVUKÇU S., İRKEN G., OLGUN N., GÜÇLÜ A.
Pediatrics International
, vol.37, no.5, pp.638-641, 1995 (SCI-Expanded)
1994
1994Assessment of clinical impact and predisposing factors for neonatal thrombocytopenia
ÖREN H., Irken G., Ören B., Olgun N., ÖZKAN H.
The Indian Journal of Pediatrics
, vol.61, no.5, pp.551-558, 1994 (SCI-Expanded)
1993
1993Immunoblastic sarcoma arising in angioimmunoblastic lymphadenopathy
Olgun N., Tavli V., KAVUKÇU S., Cevik N., Gogus S., Cevik N.
The Indian Journal of Pediatrics
, vol.60, no.5, pp.688-692, 1993 (SCI-Expanded)
1993
1993NUTRITION, IMMUNITY AND INFECTIONS - T-LYMPHOCYTE SUBPOPULATIONS IN PROTEIN-ENERGY MALNUTRITION
ÖZKAN H., OLGUN N., SASMAZ E., ABACIOGLU H., OKUYAN M., CEVIK N.
JOURNAL OF TROPICAL PEDIATRICS
, vol.39, no.4, pp.257-260, 1993 (SCI-Expanded)
1993
1993PELGER-HUET ANOMALY WITH TRISOMY-18-SYNDROME
IRKEN G., OLGUN N., OREN H., OREN B., CEVIK N., SAKIZLI M.
AMERICAN JOURNAL OF HEMATOLOGY
, vol.43, no.4, pp.328-329, 1993 (SCI-Expanded)
1993
1993The effect of phototherapy on total phospholipid levels of red cell membrane in jaundiced neonates
ÖZKAN H., Olgun N., ÖREN H., Cevik N.
The Indian Journal of Pediatrics
, vol.60, no.4, pp.600-602, 1993 (SCI-Expanded)
1993
1993Diffuse erythroderma cutaneous mastocytosis with bone marrow infiltration
Olgun N., ÖREN H., Ören B., İrken G., POLAT M. A., Çevik N.
Dermatology
, vol.187, no.2, pp.127-129, 1993 (SCI-Expanded)
1992
1992ALVEOLAR RHABDOMYOSARCOMA IN A CHILD WITH DIFFUSE BONE-MARROW INVOLVEMENT AND CHROMOSOMAL TRANSLOCATION (2,13)
OLGUN N., IRKEN G., OREN H., OREN B., ALTUNGOZ O., OZEN E., et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY
, vol.9, no.4, pp.385-387, 1992 (SCI-Expanded)
1992
1992PULMONARY BLASTOMA - A RARE CASE OF CHILDHOOD MALIGNANCY
KOVANLIKAYA A., PIRNAR T., OLGUN N.
PEDIATRIC RADIOLOGY
, vol.22, no.2, pp.155, 1992 (SCI-Expanded)
1992
1992KAWASAKI SYNDROME
OLGUN N., ÖZKAN H., OREN H., ERDEM N., CEVIK N.
TURKISH JOURNAL OF PEDIATRICS
, vol.34, no.2, pp.115-120, 1992 (SCI-Expanded)
Articles Published in Other Journals
2024
2024Investigation of Cancer Stem Cell Surface Markers In The Tumor Tissues of Patients Who Had Liver Transplantation Due To Hepatocellular Cancer And Evaluation of The Effect of These Markers on Prognosis
Egeli T., Unek T., Aysal Ağalar A., Ünek İ. T., Agalar C., Özbilgin M., et al.
Journal of Basic and Clinical Health Sciences
, vol.8, no.3, pp.704-709, 2024 (ESCI)
2024
2024Bone Cancer Metastatic Model on Pla Scaffold with Breast Cancer Cell Lines
Bekcioğlu Ö., Aydın M., Hüsemoğlu B., Aktaş S., Havıtcıoğlu H., Olgun H. N.
Turk J Hip Surg
, vol.4, no.3, pp.209-213, 2024 (Peer-Reviewed Journal)
2024
2024The Effect of Oral Care Protocols on Mucositis in Pediatric Cancer Patients: A Randomized Controlled Trial
Özalp Gerçeker G., Yıldırım B. G., Önal A., Bektaş M., Leblebici A., Ören H., et al.
JOURNAL OF CONTEMPORARY MEDICINE , vol.14, no.4, pp.180-188, 2024 (Peer-Reviewed Journal)
2024
2024Assessment of Ferroptotic Cell Death and Related Treatment Targets in Neuroblastoma.
Sanlav G., Altun Z. S., Olgun H. N.
Anatolian Journal of General Medical Research
, vol.34, no.2, pp.125-132, 2024 (Peer-Reviewed Journal)
2024
2024THE INVESTIGATION OF PROTECTIVE ROLE OF ACETYL L-CARNITINE ON CISPLATIN MYELOSUPPRESSION IN EXPERIMENTAL ANIMAL MODEL
KIZMAZOGLU D., İNCE D., AKTAŞ S., ALTUN Z. S., YILMAZ O., OLGUN H. N., et al.
IZTU Journal of Medical and Health Sciences , vol.2, no.2, pp.53-62, 2024 (Peer-Reviewed Journal)
2023
2023Superoxide Dismutase 2 protein levels in blood may act as a prognostic marker for high-risk neuroblastoma patients.
Demir A. B., Altun Z. S., Aktaş S., Olgun H. N.
JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES
, vol.7, no.1, pp.196-213, 2023 (ESCI)
2023
2023Noroblastomda Molekuler Heterojenite Ve Klinik Onemi - Molecular Heterogeneity In Neuroblastoma And Its Clinical Significance
Aktaş T. Ç., Aktaş S., Serinan E. Ö., Erçetin A. P., Aydın M., Gökbayrak Ö. E., et al.
Journal of Dr. Behcet Uz Children's Hospital
, vol.14238, pp.1-5, 2023 (ESCI)
2023
2023Molecular Heterogeneity in Neuroblastoma and Its Clinical Significance
Aktas T. C., AKTAŞ S., Serinan E. O., Aydin M., Gokbayrak O. E., Erol A., et al.
JOURNAL OF DR BEHCET UZ CHILDRENS HOSPITAL
, no.2, pp.123-129, 2023 (ESCI)
2022
2022SİSPLATİNE BAĞLI OTOTOKSİSİTEDE DARBEPOETİNİN KORUYUCU ROLÜ
Bayrak A. F., Olgun Y., Evin Eskicioğlu H., Kum Özşengezer S., Serinan E. Ö., Kolatan E. H., et al.
Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi
, vol.36, no.3, pp.309-320, 2022 (Peer-Reviewed Journal)
2022
2022The Significance of Histopathologic Assessment in Bone Marrow Disease in Neuroblastoma
Ekmekci S., Ince D., Olgun N., Ozer E.
TURKISH JOURNAL OF PATHOLOGY
, vol.38, no.2, pp.99-105, 2022 (ESCI)
2022
2022Malignant Ectomesenchymoma of Pelvis in an Infant
Çağaptay S., Olgun H. N., Özer E.
Türkiye Klinikleri Journal of Case Reports , vol.30, no.1, pp.62-66, 2022 (Peer-Reviewed Journal)
2021
2021Neuroblastoma-targeted Anticancer Drug Delivery
AKTAŞ S., GÖKBAYRAK Ö. E., EROL A., OLGUN H. N.
Journal of Dr. Behcet Uz Children s Hospital
, vol.11, no.3, pp.29-225, 2021 (ESCI)
2021
2021Promising Candidate As An Anticancer Agent For Childhood, A Sesquiterpene Lactone: Dehydroleucodine
EROL A., GÖKBAYRAK Ö. E., AKTAŞ S., OLGUN H. N.
International Journal For Research In Biology & Pharmacy
, vol.7, no.8, pp.1-8, 2021 (Peer-Reviewed Journal)
2021
2021Evaluation of the Effect of Mesenchymal Stem Cells on Cisplatin Induced Toxicity in Neuroblastoma Tumor Model
AKTAŞ S., OLGUN Y., EVİN H., ERÇETİN A. P., Aktaş T., YILMAZ O., et al.
International Journal of Medical Science and Clinical Invention
, vol.8, no.16, pp.5836-5848, 2021 (Peer-Reviewed Journal)
2021
2021The Effects Of Cisplatin And Oleuropein in Neuroblastoma
Dursun D., Altun Z. S., Tütüncü M., Serinan E., Aktaş S., Olgun H. N.
J Basic Health Sci , vol.5, no.S1, pp.982-990, 2021 (ESCI)
2021
2021The Effect of Ifosfamide and Mifamurtide Loaded Cement on The Viability of Osteosarcoma Cells
Bekçioğlu Ö., AKTAŞ S., AYDIN M., OLGUN H. N.
Turkish Journal of Hip Surgery , vol.1, no.3, pp.90-95, 2021 (Peer-Reviewed Journal)
2021
2021Neuroblastoma and Hippo Signaling Pathway
Ozsengezer S. K., Altun Z. S., Olgun N.
IZMIR DR BEHCET UZ COCUK HASTANESI DERGISI
, vol.11, no.1, pp.1-8, 2021 (ESCI)
2020
2020Producing Longlasting Education Material For Oncology By Prolonged Tissue Processing: Preliminary Study
Tutuncu M., AKTAŞ S., DİNİZ ÜNLÜ A. G., ALTUN Z. S., OLGUN H. N.
The journal of Tepecik Education and Research Hospital , vol.30, no.1, pp.49-52, 2020 (Peer-Reviewed Journal)
2020
2020Effect of Mesenchymal Stem Cells on Cochlear Cell Viability After Cisplatin Induced Ototoxicity
Erçetin A. P., Olgun Y., Aktaş S., Aydin M., Evin Eskicioğlu H., Altun Z. S., et al.
JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES
, vol.4, no.3, pp.378-383, 2020 (ESCI)
2020
2020Repositioning of Metformin: Anticancer Agent for Hypoxic Neuroblastoma Cells
Surer S. I., Toksoz F., Bayrak S., Meco H. E., Sever T., Başbınar Y., et al.
JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES
, vol.4, no.3, pp.384-390, 2020 (ESCI)
2018
2018CYTOTOXIC AND MOLECULAR MECHANISMS IN OTOTOXICITY OF CISPLATIN
ÇAKIR D. Ü., ALTUN Z. S., OLGUN H. N.
Journal of Scientific Perspectives , vol.2, no.2, pp.43-60, 2018 (Peer-Reviewed Journal)
2018
2018Analysis of sporadic neuroblastic tumors reveals a novel PHOX2B mutation in neuroblastoma
Caglar H. O., Tumer S., Olgun H. N., Altungöz O.
GENE REPORTS
, vol.11, pp.239-243, 2018 (ESCI)
2017
2017Bilateral breast cancer with neurofibromatosisi type 1 patient case report
Dursun D., AKTAŞ S., ALTUN Z. S., OLGUN H. N.
Eur J Breast health
, vol.4, no.13, pp.213-215, 2017 (Peer-Reviewed Journal)
2017
2017Bilateral Breast Cancer with Neurofibromatosis Type 1 Patient: Case Report
Dursun D., AKTAŞ S., ALTUN Z. S., Olgun N.
EUROPEAN JOURNAL OF BREAST HEALTH
, vol.13, no.4, pp.213-215, 2017 (ESCI)
2016
2016Kolorektal Kanser ve İmmunoterapi
Çokmert S., ALTUN Z. S., ÖZTOP İ., AKTAŞ S., OLGUN H. N.
DEÜ Tıp Fakültesi dergisi
, vol.30, no.3, pp.131-137, 2016 (Peer-Reviewed Journal)
2016
2016The Relationship Between Apoptotic Activity and Prognostic Factors in Neuroblastomas
Ekmekci S., Olgun N., ÖZER E.
TURKISH JOURNAL OF PATHOLOGY
, vol.32, no.2, pp.99-104, 2016 (ESCI)
2016
2016Does silymarin combined with cisplatin affect neuroblastoma cell death via pro-inflammatory cytokine production?
ALTUN Z. S., Cecen E., Pamukoglu A., AKTAŞ S., Olgun N.
IZMIR DR BEHCET UZ COCUK HASTANESI DERGISI
, vol.6, no.1, pp.37-45, 2016 (ESCI)
2016
2016Silmarin nöroblastom hücrelerinde pro inflamatuvar sitokin üretimini süzenleyerek sisplatin ile birlikte hücre ölümünü etkiler mi
ALTUN Z. S., Çecen E., Pamukoğlu A., AKTAŞ S., OLGUN H. N.
İzmir Behçet Uz Çocuk Hastanesi Dergisi , vol.6, no.1, pp.37-45, 2016 (Peer-Reviewed Journal)
2015
2015Pleuropulmonary Blastoma: A Case Report
Ekmekci S., AYSAL AĞALAR A., Olgun N., OLGUNER M., Cakmakci H., ÖZER E.
TURKISH JOURNAL OF PATHOLOGY
, vol.31, no.1, pp.68-71, 2015 (ESCI)
2015
2015Nonpigmented Metastatic Melanoma in a Two-Year-Old Girl: A Serious Diagnostic Dilemma
Diniz G., Yildirim H. T., Yamaci S., Olgun N.
CASE REPORTS IN ONCOLOGICAL MEDICINE
, vol.2015, 2015 (ESCI)
2013
2013Kanser Tedavisi Gören Çocuklarda Tedavinin Diş Gelişimine olan Geç Yan Etkileri (Dört Olgu Sunumu)
KILINÇ G., BULUT G. F., OLGUN H. N., Demirağ B., İRKEN G., ERTUĞRUL F., et al.
Atatürk Üniversitesi Diş Hekimliği Fakültesi Dergisi
, vol.23, no.7, pp.48-54, 2013 (Peer-Reviewed Journal)
2013
2013Nörofibromatozis Tip 1 Olgularında Dna Tamir Genlerinin Ekspresyonunun Klinik Önemi Clınıcal Sıgnıfıcance Of Dna Repaır Genes Expressıons In Neurofıbromatosıs Type 1 Cases Duygu Dursun1 Safiye Aktaş1 Ayşe Pınar Erçetin1 Zekiye Altun1 Kamer Mutafoğlu2 Nur Olgun2
DUYGU D., AKTAŞ S., ERÇETİN A. P., ALTUN Z. S., MUTAFOĞLU K., OLGUN H. N.
Nörofibromatozis Tip 1 Olgularında Dna Tamir Genlerinin Ekspresyonunun Klinik Önemi , vol.27, no.1, pp.15-23, 2013 (Peer-Reviewed Journal)
2008
2008Prognostic significance of cyclooxygenase-2 expression in pediatric Hodgkin and non-Hodgkin lymphomas with or without Epstein-Barr virus latent infection
AKTAŞ S., KargI A., Olgun N., Diniz G., Erbay A., Vergin C.
Comparative Clinical Pathology
, vol.17, no.2, pp.125-131, 2008 (Scopus)
2007
2007Clinical characteristics and therapy outcome of pediatric Hodgkin's lymphoma - A single centre experience from the west part of Turkey
Uysal K. M., Çetingöz R., Güneş D., Demiral A. N., Özer E., Çakmakçi H., et al.
Turkish Journal of Cancer
, vol.37, no.3, pp.98-108, 2007 (Scopus)
2007
2007Effects of Hydrogen Peroxide on Nitric Oxide Mediated Cellular Death in Human Cervical Carcinoma Cell Line
Başbınar Y., Olgun H. N.
Türk Hijyen ve Deneysel Biyoloji Dergisi , vol.64, no.2, pp.26-33, 2007 (Peer-Reviewed Journal)
2007
2007Translasyonel Çalışmalar İçin İn Vitro Nöroblastoma Sağaltım Modeli
Başbınar Y., Olgun H. N.
Türk Hijyen ve Deneysel Biyoloji Dergisi , vol.64, no.3, pp.27-33, 2007 (Peer-Reviewed Journal)
2001
2001A scoring system for the effectiveness of hepatitis-B vaccination in children receiving treatment for cancer
Çorapçioǧlu F., SARIALİOĞLU F., Olgun N., Uysal K. M.
Turkish Journal of Cancer
, vol.31, no.4, pp.150-157, 2001 (Scopus)
1997
1997Torakal ekstraosseöz Ewing sarkomunda cerrahi yaklaşım
OTO Ö., HAZAN E., OKUTAN H., OLGUN N., KARGI A., ÇETİNGÖZ R., et al.
HEYBELİADA TIP BÜLTENİ , vol.3, no.1, pp.13-17, 1997 (Peer-Reviewed Journal)
1995
1995Pediatric endobronchial leıomyoma mimicking asthma
OLGUN N., ÖZAKSOY D., UÇAN E. S., TÜRKMEN A., CANDA T., OTO Ö., et al.
Respiratory Medicine , no.89, pp.581-582, 1995 (Scopus)
1992
1992Kawasaki syndrome.
Olgun N., Ozkan H., Oren H., Erdem N., Cevik N.
The Turkish journal of pediatrics
, vol.34, no.2, pp.115-20, 1992 (Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences
2024
2024Inhibition of the Hippo Signaling Pathway Component YAP in Neuroblastoma
Kum Özşengezer S., Altun Z. S., Olgun H. N., Sanlav G.
56th Congress of the International Society of Paediatric Oncology (SIOP) , Hawaii, United States Of America, 17 - 20 October 2024, vol.71, no.158, pp.158, (Summary Text)
2024
2024Investigating the Effect of SMAC Mimetic LCL-161 on Transcriptomics Changes in SH-Sy5Y Neuroblastoma Cells
Baran B., Yuan H., Sonmez E., Delek S., Aktaş S., Altun Z. S., et al.
56th Congress of the International Society of Paediatric Oncology (SIOP), Hawaii, United States Of America, 17 - 20 October 2024, vol.71, no.492, pp.492, (Summary Text)
2024
2024Potential diagnostic and prognostic biomarkers of pediatric Burkitt lymphoma identified through miRNA-Seq of tumor tissue and plasma
Küçük C., Esmeray Sönmez E., Hatipoğlu T., Yuan H., Hu X., Ceylan A., et al.
EHA2024 Hybrid Congress, 13 - 16 June 2024, pp.4005, (Summary Text)
2024
2024NÖROBLASTOMDA CERRAHİ TEMELLI VE RADYOLOJİ TEMELLI EVRELEME - RISK SINIFLAMALARININ RETROSPEKTİF DEĞERLENDİRİLMESİ
Ölmez Mart Z., İnce D., Kızmazoğlu D., Yaşar E., Çeçen R. E., Güleryüz Uçar H., et al.
23. Ulusal Pediatrik Kanser Kongresi, Aydın, Turkey, 17 - 21 April 2024, pp.78, (Summary Text)
2024
2024Nöroblastom Hücrelerinde Smac Mimetik Lcl-161 Uygulamasının RNA Sekanslama İle Gen Ekspresyonlarının Değerlendirilmesi
Baran B., Altun Z. S., Yuan H., Esmeray Sönmez E., Aktaş S., Olgun H. N.
XXIII. Ulusal Pediatrik Kanser Kongresi, Aydın, Turkey, 17 - 21 April 2024, pp.48, (Summary Text)
2024
2024Polieter İyonofor Molekül K41A Nöroblastomda Potansiyel Anti-Tümoral Etkinliğini Hücre Ölüm Yolaklarını Modüle Ederek Ortaya Çıkarır
Sanlav G., Altun Z. S., Kum Özşengezer S., Aktaş S., Bedir E., Olgun H. N.
XXIII. Ulusal Pediatrik Kanser Kongresi, Aydın, Turkey, 17 - 21 April 2024, pp.45, (Summary Text)
2024
2024Nöroblastomda ATRX ve TERT Ekspresyonlarının Rolü.
Tuncel M., Kum Özşengezer S., Kızmazoğlu D., Altun Z. S., Aktaş S., Olgun H. N.
XXIII. Ulusal Pediatrik Kanser Kongresi, Aydın, Turkey, 17 - 21 April 2024, pp.63, (Summary Text)
2024
2024Nöroblastomda Hippo Sinyal Yolaği Bileşeni Yap’ın İnhibisyonu.
Kum Özşengezer S., Altun Z. S., Sanlav G., Olgun H. N.
XXIII. Ulusal Pediatrik Kanser Kongresi , Aydın, Turkey, 17 - 21 April 2024, pp.46, (Summary Text)
2023
2023Pediatrik Solid Tümörlerde NTRK Gen Mutasyonlarının Yeni Nesil Sekanslama Analizi ile Araştırılması.
Ismayil N., Erol A., Serinan E., Gökbayrak Ö., Özdemir S. M., Kızmazoğlu D., et al.
11. Onkolojide Arayışlar Sempozyumu, İzmir, Turkey, 15 - 17 December 2023, pp.14, (Summary Text)
2023
2023Evaluation of RhoB Expression as a Prognostic Factor in Neuroblastoma
Baran B., Sanlav G., Kum Özşengezer S., Kızmazoğlu D., Aktaş S., Altun Z. S., et al.
VIII. Türkiye in vitro Diyagnostik Sempozyumu “Preklinik Modellemeler”, İzmir, Turkey, 29 November - 01 December 2023, (Unpublished)
2023
2023G6PD AS A PROGNOSTIC BIOMAKER IN NEUROBLASTOMA BY BIOINFORMATIC ANALYSIS
Yuan H., Altun Z. S., Kum Özşengezer S., Olgun H. N.
VIII. Türkiye in vitro Diyagnostik (IVD) Sempozyumu “PREKLİNİK MODELLEMELER” , İzmir, Turkey, 29 November - 01 December 2023, vol.1, no.1, pp.3-4, (Summary Text)
2023
2023Investİgatİon of GAB1 Expression in Neuroblastoma Patients.
Sanlav G., Kum Özşengezer S., Baran B., Kızmazoğlu D., Altun Z. S., Aktaş S., et al.
DEU INTERNATIONAL SYMPOSIUM SERIES ON GRADUATE RESEARCHES Life Sciences, 9 - 10 November 2023, (Unpublished)
2023
2023Hepatoselüler Kanser Nedeniyle Karaciğer Nakli Yapılan Hastaların Tümör Dokularında Kanser Kök Hücresi Yüzey Belirteçlerinin Araştırılması ve Bu Belirteçlerin Prognoza Etkisinin Değerlendirilmesi
Egeli T., Ünek T., Aysal Ağalar A., Ünek İ. T., Ağalar C., Özbilgin M., et al.
16.Türk Hepatopankreatobilier Cerrahi Kongresi, Antalya, Turkey, 09 November 2023, (Full Text)
2023
2023Vemurafenib experience in two cases with Langerhans Cell Histiocytosis unresponsive to chemotherapy
ÇEÇEN R. E., KIZMAZOĞLU D., İNCE D., ERSOY S., ÖZER E., GÜLERYÜZ UÇAR H., et al.
55th Congress of the International Society of Paediatric Oncology, OTTOWA, Canada, 11 - 14 October 2023, vol.70, pp.359-360, (Summary Text)
2023
2023MATH-1 protein expression levels in neuroblastoma may be a predictive factor for risk stratification
Sanlav G., Kum Özşengezer S., Baran B., Kızmazoğlu D., Aktaş S., Altun Z. S., et al.
SIOP, Ottawa, Canada, 11 - 14 October 2023, vol.70, no.8, pp.384, (Summary Text)
2023
2023Nöroblastomda retinoik asite bağlı diferansiasyon ve eksozom aracılı mirna ekspresyonları (TPOG adına)
ALTUN Z. S., KUM ÖZŞENGEZER S., YUAN H., KIZMAZOĞLU D., AKTAŞ S., OLGUN H. N.
XXII. Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 8 - 12 March 2023, pp.76, (Summary Text)
2023
2023Çocuk onkoloji hastalarında ve kardeşlerinde ekran ve internet bağımlılığının değerlendirilmesi
Hamiş B., Kızmazoğlu D., İnce D., Çeçen R. E., Akgöz Y., Aydemir K., et al.
XXII. Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 8 - 12 March 2023, pp.85-86, (Summary Text)
2023
2023Nöroblastom hastalarında dinutuksimab tedavisinde ekstravazasyon gelişmesi ve hemşirelik yönetimi iki olgu sunumu.
Önal A., Eser R., Olgun H. N., İnce D., Çeçen R. E., Kızmazoğlu D.
XXII. Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 8 - 12 March 2023, pp.127, (Summary Text)
2023
2023Pediatrik nöroblastik tümörlerde görüntülemeye dayalı risk faktörlerinin (IDRF) belirleyiciliği ve cerrahi tedavinin uzun dönem sonuçları.
Ulman H., Öztürk E., Ataseven E., Demirağ B., Kızmazoğlu D., Dökümcü Ü. Z., et al.
XXII. Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 8 - 12 March 2023, pp.207, (Summary Text)
2023
2023Kemoterapiye yanıtsız Langerhans Hücreli Histiositoz tanılı iki olguda vemurafenib deneyimi.
Ersoy S., Kızmazoğlu D., Çeçen R. E., İnce D., Özer E., Güleryüz Uçar H., et al.
XXII. Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 8 - 12 March 2023, pp.197, (Summary Text)
2023
2023Kemoterapi ve immünoterapi alan relaps refrakter nöroblastom tanılı hastalarda yan etkilerin değerlendirilmesi.
Kızmazoğlu D., Çeçen R. E., İnce D., Laleoğlu P., Önal A., Olgun H. N.
XXII. Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 8 - 12 March 2023, pp.206, (Summary Text)
2023
2023NÖROBLASTOMDA TÜMÖR SUPRESÖR GEN ETKISI: FBXW7 GENININ YENI NESIL SEKANS ANALIZI ILE ARAŞTIRILMASI
Erol A., Aktaş T. Ç., Gökbayrak Ö. E., Kızmazoğlu D., Aktaş S., Olgun H. N.
22. Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 8 - 12 March 2023, vol.087, pp.231, (Summary Text)
2023
2023Pediatrik Hematoloji Ve Onkoloji Hastalarında Kapalı İntravenöz Kateter Sisteminin Kateter Girişim Başarısına, Kalış Süresine Ve Komplikasyon Gelişimine Etkisi
ÖZALP GERÇEKER G., ÖNAL A., Yıldırım B. G., BEKTAŞ M., ÖREN H., OLGUN H. N.
XXII. Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 08 March 2023, (Summary Text)
2023
2023Retinoic Acid-Induced Differentiation and Exosome-Mediated miRNA Expressions in Neuroblastoma (For TPOG)
Altun Z. S., Kum Özşengezer S., Yuan H., Kızmazoğlu D., Aktaş S., Olgun H. N.
XXII. TPOG Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 8 - 12 March 2023, pp.76, (Summary Text)
2023
2023Sisplatin ototoksisitesinde gen değişimi düzeyinde yeni biyobelirteç geliştirme (TPOG ADINA)
Kızmazoğlu D., Erol A., Aktaş T. Ç., Olgun Y., Demir A. B., Altun Z. S., et al.
XXII. TPOG Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 8 - 12 March 2023, pp.77, (Summary Text)
2023
2023PD1, PDL1 POZITIFLIĞI SAPTANAN REFRAKTER LENFOMA OLGULARINDA NIVOLUMAB DENEYIMIMIZ
Laleoğlu P., Kızmazoğlu D., Hamiş B., İnce D., Çeçen R. E., Tüfekçi Ö., et al.
22.Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 8 - 12 March 2023, vol.044, pp.176, (Summary Text)
2023
2023Merkezimizde tedavi edilen çocukluk çağı lenfomaları ve solid organ tümörlerinde epidemiyoloji ve sağkalım özellikleri.
Acun B., Kızmazoğlu D., İnce D., Çeçen R. E., Olgun H. N.
XXII. Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 8 - 12 March 2023, pp.151, (Summary Text)
2023
2023TREATMENT EXPERIENCE OF CHILDHOOD HEAD AND NECK HEMANGIOMAS
Kızmazoğlu D., Olgun H. N.
IFOS, Dubai, United Arab Emirates, 17 - 21 January 2023, pp.1-2, (Summary Text)
2022
2022Evaluation of Yap-1 in Risk Classes and Prognosis in Neuroblastoma
Kum Özşengezer S., Aktaş S., Altun Z. S., Sanlav G., Baran B., Kızmazoğlu D., et al.
Dokuz Eylul University INTERNATIONAL SYMPOSIUM SERIES ON GRADUATE RESEARCHES 2022, İzmir, Turkey, 4 - 05 November 2022, pp.20, (Summary Text)
2022
2022EFFECT OF METFORMIN AND CISPLATIN COMBINATION THERAPY ON IN VITRO HYPOXIC NEUROBLASTOMA MODEL
Bayrak Ö., Bayrak S., Olgun H. N., Başbınar Y.
10. Onkolojide Arayışlar Sempozyumu, İzmir, Turkey, 16 - 18 December 2022, pp.18-19, (Summary Text)
2022
2022Nöroblastomda Yeni Tedavi Adayı Olarak Kanser Kök Hücre Belirteçlerinin İn Silico Değerlendirilmesi
Aktaş T. Ç., Serinan E., Aktaş S., Olgun H. N.
EurasianBioChem 2022 ., Ankara, Turkey, 23 - 25 November 2022, pp.1256, (Full Text)
2022
2022Pediatrik Nadir Tümörlerde Yeni Nesil Dizileme ile Pankanser Panelin Rolü
Aktaş T. Ç., Kızmazoğlu D., Aktaş S., Olgun H. N.
EurasianBioChem 2022 5th international eurasian conference on biological and chemical sciences, Ankara, Turkey, 23 - 25 November 2022, pp.1262, (Summary Text)
2022
2022Pediatrik Burkitt lenfomalarda miRNA-seq ile belirlenen miRNA seviyelerinin non-invazif tanı biyobelirteç potansiyelleri
Esmeray Sönmez E., Hu X., Yuan H., Anar A., Hatipoğlu T., Önder Siviş Z., et al.
48. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2022, (Unpublished)
2022
2022INTEGRATIVE ANALYSIS OF FEN1 EXPRESSION AND PROGNOSTIC IMPACT IN NEUROBLASTOMA
Yuan H., Altun Z. S., Olgun H. N.
The 54th Congress of the International Society of Paediatric Oncology, Barcelona, Spain, 28 September - 01 October 2022, vol.69, no.29952, pp.225, (Summary Text)
2022
2022LYMPHOMA AND SOLID TUMORS AMONG ADOLESCENTS 15-19 YEARS OF AGE: SINGLE CENTER EXPERIENCE
Kızmazoğlu D., Çeçen R. E., İnce D., Olgun H. N.
The 54th Annual Congress of the International Society of Paediatric Oncology, Barcelona, Spain, 28 September - 01 October 2022, pp.1566, (Summary Text)
2022
2022WILMS TUMOR: SINGLE CENTER EXPERİENCE
Çeçen R. E., Kızmazoğlu D., Karataş E., Coşkuner D., Umay C., Ulusoy O., et al.
The 54th Annual Congress of the International Society of Paediatric Oncology, Barcelona, Spain, 28 September - 01 October 2022, pp.1686, (Summary Text)
2022
2022Incidence, risk factors and outcome of thrombotic events in pediatric cancer patients
Çeçen R. E., Kızmazoğlu D., Tüfekçi Ö., Yılmaz Ş., İnce D., Olgun H. N., et al.
XXX. Congress of the International Society on Thrombosis and Haemostasis 2022 , London, England, 9 - 13 July 2022, pp.499, (Summary Text)
2022
2022THE RESPONSE OF LORLATINIB TREATMENT COMBINED WITH CHEMOTHERAPY AND CRANIOSPINAL RADIOTHERAPY ON CENTRAL NERVOUS SYSTEM RELAPSE OF HIGH-RISK NEUROBLASTOMA WITH ALKF1174 L MUTATION
Çeçen R. E., İnce D., Aktaş S., Kızmazoğlu D., Güleryüz Uçar H., Aktaş T., et al.
The 54th Annual Congress of the International Society of Paediatric Oncology, Barcelona, Spain, 28 September - 01 October 2022, pp.1821, (Summary Text)
2022
2022DINUTUXIMAB BETA-BASED CHEMO-IMMUNOTHERAPY FOR RELAPSED/REFRACTORY HIGH-RISK NEUROBLASTOMA: PRELIMINARY RESULTS
Olgun H. N., Çeçen R. E., İnce D., Kızmazoğlu D., Baysal B., Önal A., et al.
The 54th Congress of the International Society of Paediatric Oncology, Barcelona, Spain, 28 September - 01 October 2022, vol.167, no.1786, pp.225, (Summary Text)
2022
202225 YEARS OF LANGERHANS CELL HISTIOCYTOSIS EXPERIENCE OF A SINGLE CENTER
İnce D., Kızmazoğlu D., Çeçen R. E., Güleryüz Uçar H., Özer E., Olgun H. N.
The 54th Annual Congress of the International Society of Paediatric Oncology, Barcelona, Spain, 28 September - 01 October 2022, pp.1859, (Summary Text)
2022
2022THERAPEUTIC IMPLICATIONS OF TARGETED SEQUENCING AND miRNA-SEQ OF B CELL LYMPHOMAS
Esmeray Sönmez E., Hatipoğlu ., Hu X., Yuan H., Erşen Danyeli A., Anar Arici ., et al.
1st International Basic Oncology Congress, 2 - 04 June 2022, vol.5, pp.31, (Summary Text)
2022
2022PRECISION MEDICINE IN NEUROBLASTOMA: EXPERIENCE WITH NEXT GENERATION SEQUENCING
Aktaş T. Ç., Kızmazoğlu D., Aktaş S., Gökbayrak Ö., Çeçen R. E., İnce D., et al.
1st International Basic Oncology Congress. , İstanbul, Turkey, 2 - 04 June 2022, vol.5, no.1134059, pp.40, (Summary Text)
2022
2022Analysis of Tribbles Homolog 3 (TRIB3) Expression Levels in Neuroblastoma: Preliminary study
Baran B., Sanlav G., Kızmazoğlu D., Kum Özşengezer S., Altun Z. S., Aktaş S., et al.
1st International Basic Oncology Congress, İstanbul, Turkey, 2 - 04 June 2022, vol.2021, no.1137378, pp.56, (Summary Text)
2022
2022S-100 Protein Expression Levels as a Potential Prognostic Marker in Neuroblastoma
Sanlav G., Baran B., Kızmazoğlu D., Kum Özşengezer S., Aktaş S., Altun Z. S., et al.
1st International Basic Oncology Congress, İstanbul, Turkey, 2 - 04 June 2022, vol.2021, no.1136890, pp.55, (Summary Text)
2022
2022INVESTIGATION OF THE POTENTIAL EFFECTS OF YAP-1 AND NESTIN ON RISK CLASSES AND PROGNOSIS IN NEUROBLASTOMA
Kum Özşengezer S., Baran B., Kızmazoğlu D., Sanlav G., Aktaş S., Aktaş T., et al.
1st International Basic Oncology Congress, İstanbul, Turkey, 2 - 04 June 2022, vol.2021, no.1136813, pp.60, (Summary Text)
2022
2022Heterogenetiy for Immune and Inflamatuar Response in Neruoblastoma
Aktaş T., Kızmazoğlu D., Aktaş S., Serinan E., Çeçen R. E., İnce D., et al.
VII. Türkiye in vitro Diyagnostik Sempozyumu, İzmir, Turkey, 27 - 29 April 2022, pp.10, (Summary Text)
2022
2022The effect of SMAC mimetic on apoptotic gene expressions
Baran B., Altun Z. S., Yuan H., Aktaş S., Olgun H. N.
4th Congress of Cell Death Research Society-Turkiye with International Participation, İzmir, Turkey, 17 - 19 March 2022, vol.1, no.24, pp.81-82, (Summary Text)
2021
2021Stemness Related Genes Cause Resistance to SMAC mimetics in Neuroblastoma Cells.
Baran B., Altun Z. S., Holyavkin C., Olgun H. N.
EACR-AstraZeneca Virtual Conference ‘Drug Tolerant Persister Cells, London, United Kingdom, 07 December 2021, pp.8, (Summary Text)
2021
2021S11 Çocukluk çağı solid tümörlerinde retinoik asitin PI3K/AKT ve RAS/MAPK yolakları üzerine etkisinin western blot yöntemi ile saptanması
Gökbayrak Ö. E., Aktaş S., Erol A., Altun Z. S., Olgun H. N.
XXI. Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 24 - 28 November 2021, pp.76, (Summary Text)
2021
2021S 07 Nöroblastomda yeni nesil sekanslama ile moleküler heterojenite değerlendirilmesi (TPOG adına)
Aktaş T., Yuan H., Gökbayrak Ö. E., Serinan E., Erol A., Aktaş S., et al.
XXI. Ulusal Pediatrik Kanser Kongresi, Antalya, Turkey, 24 - 28 November 2021, no.7, pp.71, (Summary Text)
2021
2021Effect of MSCs on Cisplatin Toxicity in Neuroblastoma Model
AKTAŞ S., EVİN ESKİCİOĞLU H., ERÇETİN A. P., Aktaş T., YILMAZ O., KIRKIM G., et al.
3. International Baku Scientific Research Congress The Book of Full Text, Baku, Azerbaijan, 13 July 2021, pp.801-816, (Full Text)
2021
2021Nöroblastomda Anti-Tümör Ajanı Olarak SMAC Mimetiklerin Kullanımı
Altun Z. S., Baran B., Olgun H. N., Aktaş S.
9. Onkolojide Arayışlar Sempozyumu, İzmir, Turkey, 12 - 13 November 2021, pp.12-13, (Summary Text)
2021
2021Treatment of Relapse/ Refractory Neuroblastoma: Dokuz Eylul Experience
Çeçen R. E., İnce D., Kızmazoğlu D., Akyol Ş., Özdoğan Ö., Özer E., et al.
Virtual 53rd Congress of the International Society of Paediatric Oncology, 21 - 24 October 2021, vol.68, no.5, pp.215-216, (Summary Text)
2021
2021EVALUATION OF THE EFFECT OF MESENCHYMAL STEM CELLS ON CISPLATIN INDUCED TOXICITY IN NEUROBLASTOMA TUMOR MODEL
AKTAŞ S., OLGUN Y., KIRKIM G., EVİN ESKİCİOĞLU H., ERÇETİN A. P., Aktaş T. Ç., et al.
3. INTERNATIONAL BAKU SCIENTIFIC RESEARCH CONGRESS, Baku, Azerbaijan, 15 - 16 October 2021, (Full Text)
2021
2021CAULERPIN FROM CAULERPA CYLINDRACEA INHIBITS CELL PROLIFERATION, MIGRATION AND INVASION IN HCT-116 HUMAN COLORECTAL CANCER CELL LINE
Mert Ozupek N., Cavaş L., Olgun H. N., Ellidokuz H., Başbınar Y.
3rd International Cancer and Ion Channels Congress (CANCERION-2021), İstanbul, Turkey, 16 - 18 September 2021, pp.57, (Summary Text)
2021
2021Erythrocyte and platelet transfusion practises in pediatric hematology and oncology patients and investigation of their effects on outcome
Ateş Ş. U., Tüfekçi Ö., Yılmaz Ş., İnce D., Çeçen R. E., Olgun H. N., et al.
European Hematology Association, 26 th congress, Amsterdam, Netherlands, 13 - 16 June 2021, pp.860-861, (Summary Text)
2021
2021An in-silico investigation of the interactions among Caulerpa secondary metabolites and colorectal cancer targets
Mert Özüpek N., Çavaş L., Ellidokuz H., Başbınar Y., Olgun H. N.
EACR 2021 Virtual Congress, 8 - 09 March 2021, pp.1, (Summary Text)
2021
2021The Effects of CDDP and OLE in Neuroblastoma
Dursun D., Altun Z. S., Tütüncü M., Serinan E., Aktaş S., Olgun H. N.
Covid-19 Pandemisinde Araştırma-Yayın ve Eğitim Süreçlerine Bakış Kongresi, İzmir, Turkey, 15 - 16 January 2021, pp.24, (Full Text)
2020
2020Audiological evaluation of the effect of Darbepoetin on the prevention of cisplatin ototoxicity
BAYRAK F., OLGUN Y., ESKİCİOĞLU E., SERİNAN E., KOLATAN H. E., ÇETİNAYAK H. O., et al.
2nd Interational Medical Congress Of Izmir Democracy University- Healty Aging and Aging ’xxasssoicated Diseases , online, 17 - 19 December 2020, (Summary Text)
2020
2020The investigation of protective role of Acetyl L-Carnitine on cisplatin myelosuppression in experimental animal models
KIZMAZOĞLU D., İNCE D., AKTAŞ S., ALTUN Z. S., KOLATAN H. E., YILMAZ O., et al.
2nd International Medical Congress of Izmir Democracy University, Healty Aging anbd Aging-Associated Diseases, IMCUDU 2020, online izmir, 17 - 19 December 2020, pp.175-177, (Full Text)
2020
2020Investıgatıon Of The Effects Of Cısplatın And Paclıtaxel On Stem Cell Markers And Cell Death Mechanısms In Ovarıan Cancer
KUM ÖZŞENGEZER S., ÇUMRALI S., ALTUN Z. S., OLGUN H. N.
2nd International Medical Congress of Izmir Democracy University, Healty Aging anbd Aging-Associated Diseases, İzmir online, Turkey, 17 - 19 December 2020, pp.530-534, (Full Text)
2020
2020Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol Low Risk Group Treatment Results
İNCE D., KURUCU N., VARAN A., AKICI F., DEMİRAĞ B., ÇEÇEN R. E., et al.
PEDIATRIC BLOOD CANCER, Ottawa, Canada, 14 - 17 October 2020, vol.67, pp.308-309, (Summary Text)
2020
2020Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol Low Risk Group Treatment Results
İNCE D., KURUCU N., VARAN A., AKICI F., DEMİRAĞ B., ÇEÇEN R. E., et al.
PEDIATRIC BLOOD CANCER, Ottawa, Canada, 14 - 17 October 2020, vol.67, pp.308-309, (Summary Text)
2020
2020Turkish Pediatric Oncology Group Neuroblastoma 2009 Protocol Low Risk Group Treatment Results
İNCE D., KURUCU N., VARAN A., AKICI F., DEMİRAĞ B., ÇEÇEN R. E., et al.
PEDIATRIC BLOOD CANCER, Ottawa, Canada, 14 - 17 October 2020, vol.67, pp.308-309, (Summary Text)
2020
2020THE EFFECT OF FUCOİDAN AND CISPLATIN ON DNA DAMAGE RELATED GENES IN COCHLEAR CELLS
Tütüncü M., Kum Ozsengezer S., Olgun Y., Altun Z. S., Olgun H. N.
52nd congress of the International Society of Paediatric Oncology (SIOP), Ottawa, Canada, 14 - 17 October 2020, pp.1, (Summary Text)
2020
2020Pediatrik Hematoloji-Onkoloji Hastalarında Sanal Gerçekliğin Port İğnesi Değişimi Sırasında Yaşanan Ağrı, Korku ve Aksiyeteye Etkisi: Randomize Kontrollü Çalışma
ÖZALP GERÇEKER G., BEKTAŞ M., AYDINOK Y., ÖREN H., ELLİDOKUZ H., OLGUN H. N.
Uluslararası 2. Dr. Behçet Uz Çocuk Kongresi, 4 - 07 March 2020, (Summary Text)
2020
2020SKOV-3 OVER KANSER HÜCRESİNDE SİSPLATİN VE PAKLİTAKSELİN KÖK HÜCRE BELİRTEÇLERİNe VE HÜCRE ÖLÜM MEKANİZMALARINA ETKİSİNİN ARAŞTIRILMASI
KUM ÖZŞENGEZER S., ÇUMRALI S., ALTUN Z. S., OLGUN H. N.
VII. Nadir Tümörler Sempozyumu, İzmir, Turkey, 28 February - 01 March 2020, pp.34, (Summary Text)
2020
2020TGF-B ile indüklenmiş epitelyal-mezenkimal dönüşüm hipoksik mikroçevrede HIF1-α ile ilişkilidir
KARACA C., KURTER H., ÇALIBAŞI KOÇAL G., ELLİDOKUZ H., OLGUN H. N.
V.Türkiye İn Vitro Diyagnostik Sempozyumu, İzmir, Turkey, 19 - 21 February 2020, (Summary Text)
2019
2019Single Center Experience of Non-Rhabdomyosarcoma Soft Tissue Tumors
İnce D., Akyol Ş., Kızmazoğlu D., Baysal B., Olguner M., Demiral A. N., et al.
51st Congress of the International Society of Paediatric Oncology, Hawaii, United States Of America, 23 - 26 October 2019, (Summary Text)
2019
2019The Effect of Oleuropein against cisplatin-induced ototoxicity by inducing DNA-damage related genes
Olgun Y., Tütüncü M., Kum Özşengezer S., Güneri E. A., Aktaş S., Altun Z. S., et al.
12th APSCI (Asia Pacific Symposium on Cochlear Implants) and Related Sciences 2019, Tokyo, Japan, 27 - 30 November 2019, (Full Text)
2019
2019stage 4s neuroblastomaexperience with the TPOG neuroblastoma treatment protocols 2003 and 2009 on behalf of TPOG
İNCE D., KURUCU N., HAZAR V., ÇEÇEN R. E., çorapçıoğlu f., öniz h., et al.
51.SIOP Congress, Lyon, France, 23 - 26 October 2019, vol.66, (Full Text)
2019
2019Juvenile Xanthogranuloma:A Single Center Experience
İNCE D., BAYSAL B., KIZMAZOĞLU D., ÖZER E., OLGUN H. N.
51st Congress of the International Society of Paediatric oncology, Lyon, France, 23 - 26 October 2019, (Full Text)
2019
2019TREATMENT OF NEUROBLASTOMA IN INFANTS YOUNGER THAN 18 MONTHS WITH THE TPOG NEUROBLASTOMA TREATMENT PROTOCOL ON BEHALF OF THE TURKISH PEDIATRIC ONCOLOGY GROUP
İNCE D., KURUCU N., VARAN A., KIZMAZOĞLU D., TOKUÇ A. G., DAĞDEMİR A., et al.
SIOP 2019-51st Annual Congress of the International Society of Paediatric Oncology, 23 - 26 October 2019, (Full Text)
2019
2019TPOG farmakogenetik (TURKPEDPGX) kohortu ilaç ilişkili toksisiteler.
Başbınar Y., Leblebici A., Kızmazoğlu D., Uncu B., Çalıbaşı Koçal G., Çıtak E. Ç., et al.
23.Ulusal Kanser Kongresi, Antalya, Turkey, 17 - 21 April 2019, pp.366, (Summary Text)
2019
2019Baş Boyun Radyoterapisi Uygulanmış Kanserli Çocuk Hastalarda Tiroid Fonksiyonlarının Değerlendirilmesi
ŞEN K., İNCE D., KIZMAZOĞLU D., SALMAN M., UMAY C., ABACI A., et al.
23.ULUSAL KANSER KONGRESİ, Turkey, 17 - 21 April 2019, pp.220, (Summary Text)
2019
2019TÜRK PEDIATRIK ONKOLOJI GRUBU ADINA GANGLIONÖROM TANILI HASTALARIN DEĞERLENDIRILMESI
KIZMAZOĞLU D., İNCE D., KURUCU N., VARAN A., ÜNAL E., ÖNİZ H., et al.
23. ULUSAL KANSER KONGRESİ, Turkey, 17 - 21 April 2019, (Summary Text)
2019
2019Nöroblastom hücrelerinde Oleuropeinin Apoptotik Hücre Ölümü Üzerine etkisi.
ALTUN Z. S., Serinan E., Tütüncü M., AKTAŞ S., OLGUN H. N.
23. Ulusal Kanser Kongresi, Antalya, Turkey, 17 - 21 April 2019, pp.319, (Summary Text)
2019
2019TPOG farmakogenetik (TURKPEDPGX) kohortu ilaç ilişkili toksisiteler
BAŞBINAR Y., leblebici a., kızmazoğlu d., uncu b., ÇALIBAŞI KOÇAL G., ÇITAK E. Ç., et al.
23. ulusal kanser kongresi, Turkey, 17 - 21 April 2019, (Summary Text)
2019
2019Sesquiterpene lactones as a candidate anti-cancer agent in childhood cancer
EROL A., AKTAŞ S., Gökbayrak Ö., KAYALAR H., OLGUN H. N.
Cancer Treatment Breast Cancer and Biomarkers, Paris, France, 20 - 21 March 2019, vol.11, (Summary Text)
2019
2019The effect of normoxic/hypoxic microenvironment on hypoxia-inducible factor 1 mechanism in neuroblastoma
TOKSÖZ F., SEVER T., İNANÇ SÜRER Ş., MEÇO H. E., KURTER H., ÇALIBAŞI KOÇAL G., et al.
International Hippocrates Congress on Medical and Health Sciences, Ankara, Turkey, 1 - 03 March 2019, pp.101-111, (Full Text)
2018
2018Whole Exome Sequencing Analysis of High Risk and Low Risk Neuroblastoma Patients (On the Behalf of Turkish Pediatric Oncology Group)
ALTUN Z. S., baran B., AKTAŞ S., YUAN H., OLGUN H. N.
2nd International Cell Death Research Congress, 1 - 04 November 2018, vol.2, pp.1530, (Full Text)
2018
2018Whole Genome Comparative Genomic Hybridization of Ewing Sarcoma Indicates Cytoskeleton, Migration and Protein Trafficking
baran B., AKTAŞ S., Tosun H., Diniz G., ÇAKIR Y., Aktaş t., et al.
2nd International Cell Death Research Congress, 1 - 04 November 2018, vol.2, pp.1547, (Full Text)
2018
2018Artificial intelligence methods for risk assessment of neuroblastoma
Leblebici A., Uncu B., Onan A., Baskın Y., Olgun H. N.
50th Congress of the International Society of Paediatric Oncology (SIOP 2018), Kyoto, Japan, 16 - 19 November 2018, pp.5-6, (Summary Text)
2018
2018A 3year review of a cohort Turkish Paediatric Oncology Group (TURKPEDPGx)
Başbınar Y., Uncu B., Leblebici A., Çalıbaşı Koçal G., Çıtak Ç., Ak E., et al.
50th Congress of the International Society of Paediatric Oncology (SIOP), Aomori, Japan, 9 - 11 November 2018, pp.1, (Summary Text)
2018
2018PO-392 Mesenchimal Stem Cell and Cisplatin Interference in Neuroblastoma Experimental Animal Model
AKTAŞ S., ERÇETİN A. P., AYDIN M., ÇALİŞİR M., BEKÇİOĞLU Ö., YILMAZ O., et al.
50th Congress of the International Society of Pediatric Oncolog, Kyoto, Japan, 14 - 16 November 2018, (Summary Text)
2018
2018Comparative Genomic Hybridisation in Neuroblastoma: A molecular Approve for Tumor Heterogeneity
Aktaş T., AKTAŞ S., BARAN B., TOSUN H., DİNİZ G., ÇAKIR Y., et al.
7.ci Multidisipliner Kanser Araştırma ve 1.ci Temel Onkoloji Kongresi, 11 - 14 October 2018, pp.129-130, (Summary Text)
2018
2018The Effects of Oleuropein on Different Clinically Types of Human Neuroblastoma Cells
ALTUN Z. S., Serinan E., Tütüncü M., AKTAŞ S., OLGUN H. N.
2nd Cell Death and Research Congress, 1 - 04 November 2018, vol.2, pp.1591, (Full Text)
2018
2018“Don’t Eat Me” Signals of Neuroblastoma by CD47 for Immune Escape: A Novel Prognostic Biomarker
AKTAŞ S., ERÇETİN A. P., Serinan E., ALTUN Z. S., OLGUN H. N.
2nd International Cell Death and Research Congress, 1 - 04 November 2018, vol.2, pp.1538, (Full Text)
2018
2018Examining Microenvironment in Osteosarcoma: Bone Greft Material Cement Does Not interfere with chemo and immunotherapy in osteosarcoma
BEKCİOGLU O., AKTAŞ S., ERÇETİN A. P., AYDIN M., KOLATAN H. E., KILIC A. İ., et al.
7. Multidisipliner Kanser Araştırma 1. Temel Onkoloji Kongresi Uluslararası Katılımlı, 11 - 14 October 2018, (Full Text)
2018
2018Radiological staging in neuroblastoma: computed tomography or magnetic resonance imaging?
SARIOĞLU F. C., Salman M., GÜLERYÜZ H., ÖZER E., ÇEÇEN R. E., İNCE D., et al.
XVI. Balkan Congress of Radiology 2018, 4 - 06 October 2018, (Summary Text)
2018
2018Isolated central nervous system Non-Hodgin lymphoma
ERDEM M., KIZMAZOĞLU D., ATLAN M. A., YILDIRIM E., ÇETİNAYAK H. O., İNCE D., et al.
6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgin Lymphoma, Rotterdam, Netherlands, 26 - 29 September 2018, pp.108, (Summary Text)
2018
2018Isolated central nervous system Non-Hodgkin lymphoma
Erdem M., Kizmazoglu D., Atlan M. A., Yildirim E., ÇETİNAYAK H. O., İNCE D., et al.
6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, Netherlands, 26 - 29 September 2018, vol.182, pp.108, (Summary Text)
2018
2018A single center experience of pediatric Hodgkin lymphoma
Ince D., Erdem M., Kizmazoglu D., Cecen E., Demiral A. N., Cetingoz R., et al.
6th International Symposium on Childhood, Adolescent and Young Adult Non-Hodgkin Lymphoma, Rotterdam, Netherlands, 26 - 29 September 2018, vol.182, pp.102, (Summary Text)
2018
2018Evaluation of ototoxicity in children with head and neck cancer who received cisplatin and /or carboplatin therapy
OLGUN Y., İNCE D., KIZMAZOĞLU D., ERDEM M., KIRKIM G., DEMİRAL A. N., et al.
15TH INTERNATIONAL CONFERENCE ON COCHLEAR IMPLANTS AND OTHER IMPLANTABLE AUDITORY TECHNOLOGY, 27 - 30 June 2018, (Summary Text)
2018
2018Paediatric sinonasal malignant masses and the mimickers
Cekdemir Y. E., Salman M., SARIOĞLU F. C., GÜLERYÜZ H., Kızmazoglu D., BAYSAL B., et al.
The 54th Annual Meeting 40th Post Graduate Course of the European Society of Paediatric Radiology (ESPR), Berlin, Germany, 18 - 22 June 2018, (Summary Text)
2018
2018Ewing sarcoma family of tumours: Beyond the bone!
SARIOĞLU F. C., Salman M., Cekdemir Y. E., GÜLERYÜZ H., Kızmazoglu D., BAYSAL B., et al.
The 54th Annual Meeting 40th Post Graduate Course of the European Society of Paediatric Radiology (ESPR), 18 - 22 June 2018, (Summary Text)
2018
2018Onsekiz aylıktan küçük süt çocukluğu dönemi nöroblastomda dokuz eylül üniversitesi deneyimi
İNCE D., KIZMAZOĞLU D., ERDEM M., AKTAŞ S., ÇEÇEN R. E., ALTUN Z. S., et al.
XX. Ulusal Pediatrik Kanser Kongresi, Turkey, 2 - 06 May 2018, (Summary Text)
2018
2018Dokuz Eylül Üniversitesi Lokalize Nöroblastom Deneyimi
İNCE D., KIZMAZOĞLU D., ÇEÇEN R. E., ERDEM M., ALTUN Z. S., AKTAŞ S., et al.
XX. Ulusal Pediatrik Kanser Kongresi, Turkey, 2 - 06 May 2018, (Summary Text)
2018
2018Baş Boyun Yerleşimli Kanser Tanısıyla Sisplatin ve /veya Karboplatin ALna Çocuklarda Ototoksisitenin Değerlendirilmesi
OLGUN Y., İNCE D., KIZMAZOĞLU D., ERDEM M., KIRKIM G., DEMİRAL A. N., et al.
XX. Ulusal Pediatrik Kanser Kongresi, Turkey, 2 - 06 May 2018, (Summary Text)
2018
2018Dokuz Eylül Üniversitesi Orta Risk Grubu NöroblastomTedavi Deneyimi
İNCE D., ERDEM M., KIZMAZOĞLU D., ÇEÇEN R. E., AKTAŞ S., ALTUN Z. S., et al.
XX. Ulusal Pediatrik Kanser Kongresi, Turkey, 2 - 06 May 2018, (Summary Text)
2018
2018TPOG-NÖROBLASTOM 2009 PROTOKOLU: YÜKSEK RISK GRUBU- OTOLOG KÖK HÜCRE TRANSPLANTASYONU TEDAVI KOLU GÜNCEL ÖN SONUÇLARI
AKSOYLAR S., ÇEÇEN R. E., EMİR S., GÜLER E., ÜNAL E., DEMİRAĞ B., et al.
XX. Ulusal Pediatrik Kanser Kongresi, BELEK-ANTALYA, Turkey, 2 - 06 May 2018, (Summary Text)
2018
2018TPOG-Nöroblastom 2009 Protokolü: Yüksek Risk Grubu-Otolog Kök Hücre Transplantasyonu Tedavi Kolu Güncel ön Sonuçları
AKSOYLAR S., ÇEÇEN R. E., emir s., GÜLER E., ÜNAL E., DEMİRAĞ B., et al.
XX. ULUSAL PEDİATRİK KANSER KONGRESİ, Turkey, 2 - 06 May 2018, (Full Text)
2018
2018TPOG Nöroblastom 2009 protokolu: Yüksek risk grubu-otolog kök hücre transplantasyonu tedavi kolu güncel ön sonuçları
AKSOYLAR S., ÇEÇEN R. E., Emir S., GÜLER E., ÜNAL E., Demirağ B., et al.
XX. Ulusal Pediatrik Kanser Kongresi, Turkey, 2 - 06 May 2018, pp.116, (Full Text)
2018
2018TPOG NÖROBLASTOMA 2009 PROTOKOL YÜKSEK RİSK GRUBU OYOLOG KÖK HÜCRE TEDAVİ KOLU GÜNCEL SONUÇLAR
AKSOYLAR S., ÇEÇEN R. E., GÜLER E., ÜNAL E., ÜNAL E., DEMİRAĞ B., et al.
UKK 2018, Turkey, 2 - 05 May 2018, (Full Text)
2018
2018TPOG-NBL 2009 Protokolü, Yüksek Risk Grubu Otolog Kök Hücre Transplantasyonu Kolu güncel sonuçları
AKSOYLAR S., ÇEÇEN R. E., Emir s., ÜNAL E., GÜLER E., DEMİRAĞ B., et al.
XX. Ulusal Pediatrik Kanser Kongresi, Turkey, 2 - 05 May 2018, (Full Text)
2018
2018Çocuklarda Kanser tedavisi sonrası uzun dönem diş anomalileri
Kılınç G., Bulut G., Ertuğrul F., Ören H., Demirağ B., Demiral A. N., et al.
Ulusal Radyoloji Kongresi, Girne, Cyprus (Kktc), 27 April - 01 May 2018, (Summary Text)
2017
2017is oluropein protective for cisplatin induced ototoxicity in HEI OC1 cells
AYDIN M., OLGUN Y., ALTUN Z. S., AKTAŞ S., OLGUN H. N.
11TH ASIA PACIFIC SYMPOSIUM ON COCHLEAR IMPLANTS AND RELATED SCIENCES, 19 September - 22 December 2017, (Summary Text)
2017
2017The effects of disodium pentaborate decahydrate on in-vivo neuroblastoma animal model
Altun Z. S., Serinan E. Ö., Aktaş S., Çalişir M., Aydın M., Yılmaz O., et al.
CLINICAL EXPERIMENTAL METASTASIS, Berlin, Germany, 27 - 29 November 2017, (Summary Text)
2017
2017The effects of disodium pentaborate decahydrate ın invivo neuroblastoma amimal model
ALTUN Z. S., serinan e., serinan e., AKTAŞ S., çalışır m., aydın m., et al.
1st Joint EACR-MRS conference Seed and Soil, 27 - 29 November 2017, (Summary Text)
2017
2017ın vivo presentation locaL EFFECT OF CADMİUM OF LOCAL RECCURENCE İN XENOGRAFT MODEL OF OSTEOSARCOMA
DEMİRKIRAN D., AKTAŞ S., ERÇETİN A. P., KOLATAN H. E., YILMAZ O., HA H., et al.
sıop 2017, Washington, Kiribati, 12 - 15 October 2017, vol.64, pp.253, (Summary Text)
2017
2017ıs oleuropein protective for cisplatin induced ototoxicity in HEI-OC1 cells
aydın m., OLGUN Y., ALTUN Z. S., AKTAŞ S., OLGUN H. N.
APSCI 2017, 19 October - 22 September 2017, (Summary Text)
2017
2017the relation of microenvironment associated gene expression with risk classification in neuroblastoma
AKTAŞ S., ERÇETİN A. P., serinan e., aydın m., ALTUN Z. S., OLGUN H. N.
SIOP 2017, 12 - 15 October 2017, vol.64, pp.222, (Summary Text)
2017
2017Evaluation of musculoskeletal complaints and skeletal involvements in children with newly diagnosed lymphoma and solid tumors
İNCE D., erdem m., yenigürbüz f., kızmazğlu d., ataseven e., GÜLERYÜZ H., et al.
SIOP 2017, 12 - 15 October 2017, vol.64, pp.208, (Summary Text)
2017
2017Treatment results in pediatric head and neck rhabdomyosarcomas a single center experience
MUTAFOĞLU K., İNCE D., kızmazoğlu d., OLGUN Y., erdem m., DEMİRAL A. N., et al.
SIOP 2017, 12 - 15 October 2017, vol.64, (Summary Text)
2017
2017Dokuz Eylul University Treatment experience of neuroblastoma
İNCE D., kızmazoğlu d., ÇEÇEN R. E., erdem m., AKTAŞ S., serinan e., et al.
SIOP2017, 12 - 15 October 2017, vol.64, pp.447, (Summary Text)
2017
2017TREATMENT OF RELAPSE NEUROBLASTOMA:dOKUZ EYLÜL uNİVERSİTY EXPERİENCE
İNCE D., ERDEM M., ÇEÇEN R. E., KIZMAZOĞLU D., ÖZER E., DEMİRAL A. N., et al.
sıop 2017, 12 - 15 October 2017, vol.64, pp.448, (Summary Text)
2017
2017Antitumor activity of flubendazole in a neuroblastoma tumor model
ÇEÇEN R. E., ALTUN Z. S., AKTAŞ S., serinan e., KOLATAN H. E., evin h., et al.
SIOP 2017, 12 - 15 October 2017, (Summary Text)
2017
2017retrospective analysis of our patients with pons glioma
İNCE D., kızmazoğlu d., erdem m., demirai a., ÇETİNGÖZ E. R., GÜLERYÜZ H., et al.
SIOP 2017, 12 - 15 October 2017, vol.64, pp.463, (Summary Text)
2017
2017Head and neck hemangiomas of chilhood :a single center experience
kızmazoğlu d., İNCE D., agralı N., erkoç e., erdem m., MUTAFOĞLU K., et al.
SIOP 2017, 12 - 15 October 2017, vol.64, pp.292, (Summary Text)
2017
2017the effects of rosiglitazone on minimal disease model of neuroblastoma
ALTUN Z. S., ayla M., pamukoğlu a., ERÇETİN A. P., OLGUN H. N.
SIOP 2017, 12 - 15 October 2017, vol.64, pp.223, (Summary Text)
2017
2017Effect of Mesenchymal stem cells on Cochlear cell Viability after Cisplatin Induced Ototoxicity
ERÇETİN A. P., OLGUN Y., AKTAŞ S., aydın m., EVİN H., ALTUN Z. S., et al.
APSCI 2017, 19 - 22 September 2017, (Summary Text)
2017
2017Comparıson of Ototoxic and Cytotoxic Effects of Cisplatin and Lipoplatin in Neuroblastoma
EVİN H., OLGUN Y., Serinan E., ALTUN Z. S., KIRKIM G., KOLATAN H. E., et al.
APSCI 2017, 19 - 22 September 2017, (Summary Text)
2017
2017Effect of mesenchymal stem cells on cochlear cell viability after cisplatin induced ototxicity
ERÇETİN A. P., OLGUN Y., AKTAŞ S., aydın m., evin h., ALTUN Z. S., et al.
11t APSCI 2017, 19 - 22 September 2017, (Summary Text)
2017
2017EFFECTS OF MESENCHYMAL STEM CELLS TUMOR INFILTRATING LYMPHOCYTESAND CANCER STEM CELLS İN THE NEUROBLASTOMA
EKİN Z., AKTAŞ S., ALTUN Z. S., SERİNAN E., ERÇETİN A. P., EKİN r., et al.
29TH eUROPEAN CONGRESS OF PATHOLOGY, 2 - 04 September 2017, vol.471, pp.352, (Summary Text)
2017
2017Head and neck hemangiomas of childhood: asingle center experience
KIZMAZOĞLU D., İNCE D., AĞRALI N., ERKOÇ E., ERDEM M., ERDAĞ T. K., et al.
İFOS 2017, 24 - 28 June 2017, (Full Text)
2017
2017combined therapy n pediatric head and neck sarcoma
MUTAFOĞLU K., İNCE D., kızmazoğlu d., OLGUN Y., erdem m., demiral A. N., et al.
IFOS2017, 24 - 28 June 2017, (Summary Text)
2017
2017Nöroblastom Tedavisinde Dokuz Eylül Üniversitesi Deneyimi
İNCE D., KIZMAZOĞLU D., ÇEÇEN R. E., ERDEM M., AKTAŞ S., SERİNAN E., et al.
22. Ulusal Kanser Kongresi, Turkey, 19 - 23 April 2017, (Summary Text)
2017
2017Relaps Nöroblastom Tedavisinde Dokuz Eylül Üniversitesi Deneyimi
İNCE D., ERDEM M., ÇEÇEN R. E., KIZMAZOĞLU D., ÖZER E., DEMİRAL A. N., et al.
22. Ulusal Kanser Kongresi, Turkey, 19 - 23 April 2017, (Summary Text)
2017
2017Nötropenik Ateş Odağı: Listeria menenjiti
ERDEM M., KIZMAZOĞLU D., İNCE D., KALEMCİ O., BELET N., KÖROĞLU T., et al.
22. Ulusal Kanser Kongresi, Turkey, 19 - 23 April 2017, (Summary Text)
2017
2017”İzoleSantral Sinir Sistemi Lenfoması”
ERDEM M., KIZMAZOĞLU D., ATTAN M., YILDIRIM E., ÇETİNAYAK H. O., İNCE D., et al.
22. Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, (Summary Text)
2017
2017İZOLE SANTRAL SİNİR SİSTEMİ LENFOMASI
ERDEM M., KIZMAZOĞLU D., ATLAN M. A., YILDIRIM E., ÇETİNAYAK H. O., İNCE D., et al.
22. ULUSAL KANSER KONGRESİ, Turkey, 19 - 23 April 2017, (Summary Text)
2017
2017Türk Pediatrik Onkoloji Grubu Türkiye çocukluk çağı kanserleri farmakogenomik kohortu (TURKPEDPGX).
BASKIN Y., ÇEÇEN R. E., KIZMAZOĞLU D., ÇITAK E. Ç., ÖNİZ H., ÇALIBAŞI G., et al.
22.Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, pp.640, (Summary Text)
2017
2017Türk Pediatrik Onkoloji Grubu (TPOG) Nöroblastom 2009 Protokolü (TPOG-NB-2009), Evre 4S Sonuçları
ÇEÇEN R. E., VARAN A., SEVİNİR B. B., HAZAR V., OCAK S., DAĞDEMİR A., et al.
XXII. Ulusal Kanser Kongresi, Turkey, 19 - 23 April 2017, (Summary Text)
2017
2017Türk Pediatrik Onkoloji Grubu Türkiye Çocukluk Çağı Kanserleri Farmakogenomik Kohortu (TURKPEDPGX)
BASKIN Y., ÇEÇEN R. E., KIZMAZOĞLU D., ÇITAK E. Ç., ÖNİZ H., ÇALIBAŞI G., et al.
22.Ulusal Kanser Kongresi, Antalya, Turkey, 19 - 23 April 2017, (Summary Text)
2017
2017Nöroblastomda kemoterapi
OLGUN H. N.
Pediatrik Solid tümörler kursu, İzmir, Turkey, 25 March 2017
2017
2017Dose of Cisplatin Ototoxicity and Cytotoxicity in Nude Mice: Preliminary Study
EVİN H., OLGUN Y., ALTUN Z. S., OLGUN H. N., YILMAZ O., KIRKIM G.
Egypt Cochlea, Kahire, Egypt, 3 - 05 February 2017, (Summary Text)
2017
2017Dose of Cisplatine Ototoxicity and Cytotoxicity in Nude Mice: Preliminary Study
YILMAZ O., OLGUN H. N., KIRKIM G., ALTUN Z. S., AKTAŞ S., OLGUN Y.
EGYPT COCHLEA-2017, 3 - 05 February 2017, (Summary Text)
2017
2017Dose of cisplatin ototxicity and cytotoxicity in nude mice:preliminary study
evin H., OLGUN Y., AKTAŞ S., ALTUN Z. S., OLGUN H. N., yılmaz O., et al.
Egypt cochlea 2017, 3 - 05 February 2017, (Summary Text)
2017
2017Treatment of Relapse Neuroblastoma: Dokuz EylulUniversity Experience
İNCE D., ERDEM M., KIZMAZOĞLU D., ÖZER E., AKTAŞ S., GÜLERYÜZ H., et al.
49th Congress of the International Society of Paediatric Oncology, 12 - 15 October 2017, vol.64, pp.26772, (Summary Text)
2016
2016Wilms tumor A single center experience
İNCE D., MUTAFOĞLU K., KIZMAZOĞLU D., DEMİRAL A. N., ÖZER E., aktürk n., et al.
The 48th Annual Congress of the International Society of Paediatric Oncology, 19 - 22 October 2016, (Summary Text)
2016
2016Paediatric Hodgkin lymphoma A single center experience from the West Part of Turkey
MUTAFOĞLU K., İNCE D., OLGUN H. N., GÜLERYÜZ H., ÖZER E., erdem m., et al.
The 48th Annual Congress of the International Society of Paediatric Oncology, 19 - 22 October 2016, (Summary Text)
2016
2016Assessment of the Clinical Importance of Molecular Basis of Neuroblastoma A Proteomic Approach
Demir A. B., Altun Z. S., Aktaş S., Olgun H. N.
48th CONGRESS OF THE INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY (SIOP), Dublin, Ireland, 19 - 22 October 2016, vol.63, pp.201, (Summary Text)
2016
2016Can High Risk Group Be Categorized As High Risk And Ultra High Risk In Neuroblastoma
Demir A. B., Aktaş S., Altun Z. S., Erçetin A. P., Olgun H. N.
48th CONGRESS OF THE INTERNATIONAL SOCIETY OF PAEDIATRIC ONCOLOGY (SIOP), Dublin, Ireland, 19 - 22 October 2016, vol.63, pp.201, (Summary Text)
2016
2016The Effects of Acetyl-L-Carnitine on Ciplatin and Radiaton Induced Apoptosis Treatment on Medulloblastoma Cells
PAMUKOĞLU KAYNAR A., ALTUN Z. S., Erçetin P., OLGUN Y., ÇETİNAYAK H. O., AKTAŞ S., et al.
6. Multidispliner Kanser Araştırma Kongresi, Konya, Turkey, 27 October 2016, (Summary Text)
2016
2016The in vitro Effect of Sanguinarine Differs on Neuroblastoma Stgem Cells based on the serum
ERÇETİN A. P., AKTAŞ S., YAVUZ B., ÖZTÜRK T., KAMAN D., SULU M., et al.
6. Multidisipliner Kanser Araştırma Kongresi, 27 - 30 October 2016, pp.49, (Summary Text)
2016
2016Anti Proliferative and Apoptosis Inducing Effect of Flubendazole on Neuroblastoma Cells
ERÇETİN A. P., ALTUN Z. S., AYDIN M., BOSKAN G., GÖKDEMİR E., KAVAK İ., et al.
6. Multidisipliner Kanser Araştırma Kongresi, 27 - 30 October 2016, pp.189, (Summary Text)
2016
2016In vitro Effect of Flubendazole on Neuroblastoma Stem Cells
ERÇETİN A. P., AKTAŞ S., GENÇ N., SERİNAN E., ALTUN Z. S., OLGUN H. N.
6. Multidisipliner Kanser Araştırma Kongresi, 27 - 30 October 2016, pp.125, (Summary Text)
2016
2016In vitro Effect of Borate Derivatives on Neuroblastoma Cells
ERÇETİN A. P., AKTAŞ S., AYDIN M., SOMEN M., PAŞAYİĞİT M., OLGUN H. N., et al.
6.Multidisipliner Kanser Araştırma Kongresi, 27 - 30 October 2016, pp.190, (Summary Text)
2016
2016The Effects of Acetyl L Carnitine on Cisplatin and Radietion Induced Apoptosis Treatment on Medulloblastoma Cells
PAMUKOĞLU KAYNAR A., ALTUN Z. S., ERÇETİN A. P., OLGUN Y., ÇETİNAYAK H. O., AKTAŞ S., et al.
6. Multidisipliner Kanser Araştırma Kongresi, 27 - 30 October 2016, pp.57, (Summary Text)
2016
2016Oncomir miR17 Tumour Suppressor miR146a miR302d and Oncogene miR19B Expression in Hepatoblastoma Patients
ECEVİT Ç., AKTAŞ S., YILDIRIM H., DEMİRAĞ B., ERBAY A., KARACA İ., et al.
The 48th Congress of the International Society of Paedriatric Oncology (SIOP), Dublin, Ireland, 19 - 22 October 2016, vol.63, pp.237, (Summary Text)
2016
2016Can High Risk Group be Categorized as High Risk and Ultra High Risk in Neuroblastoma on behalf of Turkish Society of Paediatric Oncology Group
DEMİR A. B., AKTAŞ S., ALTUN Z. S., ERÇETİN A. P., OLGUN H. N.
The 48th Congress of the International Society of Paedriatric Oncology (SIOP), 19 - 22 October 2016, vol.63, pp.200, (Summary Text)
2016
2016Evaluation of Circulating Tumor Cell Load in Neuroblastoma on behalf of Turkish Paediatric Oncology Group
AKTAŞ S., ERÇETİN A. P., ÇELİK E., ALTUN Z. S., DEMİR A. B., OLGUN H. N.
The 48th Congress of International Society of Paediatric Oncology (SIOP), Dublin, Ireland, 19 - 22 October 2016, vol.63, pp.201, (Summary Text)
2016
2016Effect of Mesenchymal Stem Cells and Tumour InfiltratingLymphocytes on Cancer Stem Cells in Neuroblastoma on behalf of TurkishPaediatric Oncology Group
YILDIRIM EKİN Z., AKTAŞ S., ERÇETİN A. P., ALTUN Z. S., Serinan E., DEMİR A. B., et al.
SİOP, 19 December - 22 October 2016
2016
2016Prospective observational nation wide study on pharmacogenomics genetics on childhood cancers in a cohort of TPOG
Baskın Y., Cecen R., Kızmazoğlu D., Çağlar Ç., Öniz H., Çalıbaşı G., et al.
48th SIOP, Dublin, Ireland, 19 - 22 October 2016, vol.63, pp.154, (Summary Text)
2016
2016Comparison of cisplatin with lipoplatin in terms of ototoxicity
Efe S., ALTUN Z. S., AKTAŞ S., OLGUN H. N.
48th SIOP congress, Dublin, Ireland, 19 - 22 October 2016
2016
2016Evaluation of Circulating Tumour Cell Load in Neuroblastoma onbehalf of Turkish Paediatric Oncology Group
AKTAŞ S., ERÇETİN A. P., Çelik E., ALTUN Z. S., DEMİR A. B., OLGUN H. N.
SİOP, 19 - 22 October 2016
2016
2016CAN HIGH RISK GROUP BE CATEGORIZED AS HIGH RISK AND ULTRA HIGH RISK IN NEUROBLASTOMA On the behalf of Turkish Pediatric Oncology Group
DEMİR A. B., AKTAŞ S., ALTUN Z. S., ERÇETİN A. P., OLGUN H. N.
SİOP, 19 - 22 October 2016
2016
2016Clinically importance of prognostic genetic markers in neuroblastoma on behalf of TPOG
Ceyhan M., ALTUN Z. S., DEMİR A. B., AKTAŞ S., OLGUN H. N.
48th SIOP Congress, Dublin, Ireland, 19 - 22 October 2016
2016
2016Pediatric Hodgkin lymphoma Asingle center experience from the west part of Turkry
MUTAFOĞLU K., İNCE D., DEMİRAL A. N., DEMİR YENİGÜRBÜZ F., Kızmazoğlu D., Armağan C., et al.
48th SIOP, Dublin, Ireland, 19 - 22 October 2016
2016
2016Oncomir miR17 Tumour Suppressor miR146a miR302d andOncogene miR19B Expressions in Hepatoblastoma Patients
Ecevit Ç., AKTAŞ S., Yıldırım H., Demirağ B., ERBAY A., KARACA İ., et al.
SİOP, 19 - 22 October 2016
2016
2016Effect of mesenchymal stem cells and tumor infiltrating lymphocytes on cancer stem cells in neuroblastoma on behalf of TPOG
YILDIRIM EKİN Z., AKTAŞ S., ERÇETİN A. P., ALTUN Z. S., Serinan E., DEMİR A. B., et al.
48th SIOP congress, Dublin, Ireland, 19 - 22 October 2016
2016
2016Assessment of the Clinical Importance of Molecular Basis ofNeuroblastoma A Proteomic Approach on behalf of Turkish PaediatricOncology Group
DEMİR A. B., ALTUN Z. S., AKTAŞ S., OLGUN H. N.
SİOP, 19 - 22 October 2016
2016
2016Single center experience of treatment for medulloblastoma
İNCE D., MUTAFOĞLU K., Erdem M., DEMİR YENİGÜRBÜZ F., ATASEVEN KULALI M., GÜLERYÜZ H., et al.
48th SIOP congress, Dublin, Ireland, 19 - 22 October 2016
2016
2016Clinically Importance of Prognostic Genetic Markers inNeuroblastoma on behalf of Turkish Paediatric Oncology Group
Ceylan M., ALTUN Z. S., DEMİR A. B., AKTAŞ S., OLGUN H. N.
SİOP, 19 - 22 October 2016
2016
2016Effect of Mesenchymal Stem Cells and Tumor Infiltrating Lymphocytes on Cancer Stem Cells in Neuroblastoma on behalf of Turkish Paediatric Oncology Group
YILDIRIM EKİN Z., AKTAŞ S., ERÇETİN A. P., ALTUN Z. S., SERİNAN E., DEMİR A. B., et al.
The 48th Congress of the International Society of Paediatric Oncology (SIOP 2016), Dublin, Ireland, 19 - 22 October 2016, vol.63, pp.201
2016
2016Assesment of clinical importance of molecular basis of neuroblastoma A ptoteomic approach on behalf of TPOG
DEMİR A. B., ALTUN Z. S., AKTAŞ S., OLGUN H. N.
48th SIOP congress, Dublin, Ireland, 19 - 22 October 2016
2016
2016Onco miR17 Tumor supressor miR146a miR302d and oncogene miR19B expressions in hepatoblastoma patients
Ecevit Ç., AKTAŞ S., Yıldırım H., Demirağ B., ERBAY A., Karaca İ., et al.
48th SIOP, Dublin, Ireland, 19 - 22 October 2016
2016
2016Prospective Observational Nationwide Study on Pharmacogenomics Genetics of Childhood Cancers in a Cohort of Turkish Paediatric Oncology Group TURKPEDPGX
Baskın Y., Çeçen R. E., Kızmazoğlu D., Çıtak E. Ç., Öniz H., Çalıbaşı G., et al.
48.Congress of International Society of Pediatric Oncology (SIOP), Dublin, Ireland, 19 - 22 October 2016, vol.63, pp.154, (Summary Text)
2016
2016A single center experience of a treatment for Medulloblastoma
İNCE D., MUTAFOĞLU K., KIZMAZOĞLU D., KIZMAZOĞLU C., ÇETİNAYAK H. O., ERDEM M., et al.
48TH CONGRESS OF THE INTERNATIONAL SOCIETY OF PEDIATRIC ONCOLOGY, Ireland, 19 - 22 October 2016, vol.63, pp.134, (Summary Text)
2016
2016Evaluation of circulating tumor cell load in neuroblastoma on behalf ofTPOG
AKTAŞ S., ERÇETİN A. P., Çelik E., ALTUN Z. S., DEMİR A. B., OLGUN H. N.
48th SIOP congress, Dublin, Ireland, 19 October - 22 September 2016, (Full Text)
2016
2016Intratubular Large Cell Hyalinizing Sertoli Cell Tumor of the Testis Presenting with Prepubertal Gynecomastia A Case Report
ÜNVER TUHAN H., ABACI A., SARSIK KUMBARACI B., ÖZTÜRK T., OLGUNER M., ÇATLI G., et al.
55rd Annual Meeting of the European Society for Paediatric Endocrinology (ESPE)., 10 - 12 September 2016, (Summary Text)
2016
2016Assessment of clinical importance of molecular basis of neuroblastoma: can high risk group be categorized as high risk and ultra-high risk?
Demir B., Aktas S., ALTUN Z. S., Ercetin P., Olgun N.
41st FEBS Congress on Molecular and Systems Biology for a Better Life, Kusadasi, Turkey, 3 - 08 September 2016, vol.283, pp.69, (Summary Text)
2016
2016The effects of electromagnetic field exposure At 900 mHz frequency emitted from mobile phones oncochlear cells
AKTAŞ S., ALTUN Z. S., Pamukoğlu A., DEMİR A. B., Saygan S., Çiçeksoy B., et al.
CHOLE 2016, 5 - 08 June 2016
2016
2016Friendship of Capsaicin and Cisplatin in HEI OC1 Cells
ALTUN Z. S., Altun K., OLGUN Y., Pamukoğlu A., OLGUN H. N.
CHOLE 2016, United Kingdom, 5 - 08 June 2016, vol.130, pp.150-151
2016
2016Türkiye çocukluk çağı kanserleri farmakogenomik farmakogenetik TURKPEDPGx çalışması TPOG kohortu
BASKIN Y., ÇEÇEN R. E., KIZMAZOĞLU D., ÇITAK E. Ç., Öniz H., ÇALIBAŞI G., et al.
19.Ulusal Pediatrik Onkoloji Kongresi, İzmir, Turkey, 4 - 08 May 2016
2016
2016MEDULLOBLASTOM TEDAVİ DENEYİMİMİZ
İNCE D., MUTAFOĞLU K., KIZMAZOĞLU D., KIZMAZOĞLU C., ÇETİNAYAK H. O., ERDEM M., et al.
19.ULUSAL PEDİATRİK KANSER KONGRESİ, Turkey, 4 - 08 May 2016, (Summary Text)
2016
2016Türkiye çocukluk çağı kanserleri farmakogenomik/genetik (TURKPEDPGX) çalışması TPOG kohortu
BASKIN Y., ÇEÇEN R. E., KIZMAZOĞLU D., ÇITAK E. Ç., Öniz H., ÇALIBAŞI G., et al.
19.Ulusal Pediatric Kanser Kongresi, İzmir-Çeşme, Turkey, 4 - 08 May 2016, pp.157-158, (Summary Text)
2016
2016Çocukluk Çağı Hodgkin Lenfomlasında Tek Merkez Deneyimi
MUTAFOĞLU K., İNCE D., DEMİRAL A. N., DEMİR YENİGÜRBÜZ F., KIZMAZOĞLU D., ARMAĞAN C., et al.
XIX. Ulusal Pediatrik Kanser Kongresi, Turkey, 4 - 08 May 2016, (Summary Text)
2016
2016Primer Tümör Bölgesine radyoterapi uygulanmış Wilms tümörlü çocuklarda tedavi sonuçlarımız
ÇETİNAYAK H. O., DEMİR YENİGÜRBÜZ F., ER İ., KURU A., UMAY C., ÇETİNGÖZ E. R., et al.
XII Ulusal Radyasyon Onkoloji Kongresi, Turkey, 20 - 24 April 2016, pp.101
2016
2016PRİMER TÜMÖR BÖLGESİNE RADYOTERAPİ UYGULANMIŞ WİLMS TÜMÖRLÜ ÇOCUKLARDA TEDAVİ SONUÇLARIMIZ
ÇETİNAYAK H. O., DEMİR YENİGÜRBÜZ F., ER İ., KURU A., UMAY C., ÇETİNGÖZ E. R., et al.
XII. ULUSAL RADYASYON ONKOLOJİSİ KONGRESİ, Antalya, Turkey, 20 - 24 April 2016, (Summary Text)
2016
2016Wilms Tumör
İNCE D., MUTAFOĞLU K., ATASEVEN KULALI M., Kızmazoğlu D., DEMİR YENİGÜRBÜZ F., Erdem M., et al.
48th SIOP Congress, Dublin, Ireland, 19 October - 22 January 2016
2015
2015Relation between clinical properties and audiovestibular findings in patients with Meniere s Disease
MUTLU B., KIRKIM G., Fulya K., MUNGAN DURANKAYA S., GÜRKAN S., OLGUN H. N., et al.
7th Meniere's Disease Inner Ear Disorders, 17 - 20 October 2015
2015
2015Analysis of genetic and non genetic risk factors for cisplatinum ototoxicity in pediatric patients
OLGUN Y., AKTAŞ S., KIRKIM G., KIZMAZOĞLU D., ERÇETİN A. P., DEMİR A. B., et al.
7TH INTERNATIONAL SYMPOSIUM ON MENIERE’S DISEASE AND INNER EAR DISORDERS, 17 - 20 October 2015, pp.56, (Summary Text)
2015
2015Rhabdomyosarcoma experience a single institution s results
MUTAFOĞLU K., İNCE D., KIZMAZOĞLU D., erdem m., ataseven e., DEMİR YENİGÜRBÜZ F., et al.
47th Congress of the International Society of Paediatric Oncology (SIOP), 8 - 11 October 2015
2015
2015Treatment results of pediatric germ cell tumors from a single institution
İNCE D., MUTAFOĞLU K., ataseven e., KIZMAZOĞLU D., erdem m., OLGUNER M., et al.
47th Congress of the International Society of Paediatric Oncology (SIOP), 8 - 11 October 2015
2015
2015Platinum induced ototoxicity in children comparison of diferent ototoxicity classification
KIRKIM G., OLGUN Y., MUNGAN DURANKAYA S., KIZMAZOĞLU D., İNCE D., MUTAFOĞLU K., et al.
7thInternational Meniere's Disease Inner Ear Disorders, 1 - 04 October 2015
2015
2015Expressions of microRNA of mix cellularity Hodgkin lymphomas are different in pediatric and adult patients
Diniz G., AKTAŞ S., Ceyhan M., Tosun Yıldırım H., Ceylan C., Oymak Y., et al.
27th European Congress of Pathology, 5 - 09 September 2015, vol.467, pp.279
2015
2015The relationship between apoptotic activity and prognostic factors in neuroblastomas
ekmekci s., OLGUN H. N., ÖZER E.
European Congress of Pathology, 5 - 10 September 2015, vol.497, pp.99, (Summary Text)
2015
2015The Protective Role of Aceytl-L-Carnitine Against Cisplatin and Radiotherapy Induced Ototoxicity: Nrf2 and Target Genes
ALTUN Z. S., PAMUKOĞLU KAYNAR A., OLGUN Y., AKTAŞ S., ÇETİNAYAK H. O., KIRKIM G., et al.
30th Politzer Society Meeting 1st World Congress of Otology, Japan, 30 June - 03 July 2015, (Summary Text)
2015
2015The protective role of acetyl L carnitine against cisplatin and radiotherapy induced ototxicity Nrf2 and target genes
ALTUN Z. S., Pamukoğlu A., AKTAŞ S., ÇETİNAYAK H. O., KIRKIM G., GÜNERİ E. A., et al.
30thPolitzer society meeting, Niigata, Japan, 30 June - 02 July 2015
2015
2015Role of expression of neural cell adhesion molecule syncam in neuroblastic tumors
ERÇETİN A. P., AKTAŞ S., DEMİR A. B., çağlar f., ALTUN Z. S., OLGUN H. N.
EACR sponsored 3th Anticancer agent Development congress, 18 - 19 May 2015, pp.47
2014
2014Frequently seen molecular abberations in neuroblastoma in turkey based on risk groups on behalf of the Turkish Society of pediatric oncology
DEMİR A. B., AKTAŞ S., ERÇETİN A. P., ALTUN Z. S., OLGUN H. N.
EACR sponsored 3th Anticancer agent development congress, 18 - 19 May 2014, pp.64
2014
2014The role ofgenetic and epigenetic alterations in neuroblastoma cells
ALTUN Z. S., Ceyhan M., AKTAŞ S., OLGUN H. N.
EACR sponsored 3th Anticancer agent Development congress, Turkmenistan, 18 - 19 May 2014, pp.190
2015
2015The protective role on NAC against cisplatin and radiotherapy induced ototoxicity Nrf2 and genes
ALTUN Z. S., Pamukoğlu A., OLGUN Y., AKTAŞ S., ÇETİNAYAK H. O., KIRKIM G., et al.
Aanticancer agent development congress, 18 - 19 May 2015, pp.132
2015
2015Role of expression neural cell adhesion molecule of syncam in neuroblastic tumors on the behalf of TPOG Neuroblastoma group
ERÇETİN A. P., AKTAŞ S., DEMİR A. B., ÇAĞLAR F., ALTUN Z. S., OLGUN H. N.
EACR Sponsored- 3rd Anticancer Agent Development Congress, 18 - 19 May 2015, pp.47, (Summary Text)
2015
2015The Effect of Acetyl-L-Carnitine on DNA Damage Related Genes Induced by Radiation and Cisplatin Treatment in Cochlear Cells
ALTUN Z. S., OLGUN Y., PAMUKOĞLU KAYNAR A., Bayrak F., DÜZENLİ U., ÇETİNAYAK H. O., et al.
10th Asia Pacific Symposium on Cochlear Implants and Related Sciences, China, 30 April - 03 May 2015, (Summary Text)
2015
2015The role of N acetyl cysteine on DNA damage related genes induced by radiation and cisplatin treatment in HEI OC1 cells
Düzenli U., OLGUN Y., ALTUN Z. S., Pamukoğlu A., ÇETİNAYAK H. O., AKTAŞ S., et al.
10thAsia pasific Symposium on Cochlear ımplants and related sciences, Beijing, China, 30 April - 03 May 2015, pp.1239
2015
2015Effect of Ecklonia Cava Polyphenol Extract in House Ear Institute Organ Corti 1 HEI OC1 Cells against Cisplatin Ototoxicity
Düzenli U., OLGUN Y., ALTUN Z. S., Pamukoğlu A., Bayrak F., AKTAŞ S., et al.
10th Asia Pacific Symposium on Cochlear Implants and Related Sciences, Beijing, China, 30 April - 03 May 2015
2015
2015The effect of acetyl L carnitine 0n DNA damage related genes induced by radiation and cisplatin treatment in cochlear cells
ALTUN Z. S., OLGUN Y., Pamukoğlu A., Bayrak F., Düzenli U., ÇETİNAYAK H. O., et al.
10th APSCI 2015, Beijing, China, 30 April - 03 May 2015, pp.1241
2015
2015Effect of Ecklonia Cava polyphenol Extract in HEI OC1 cells against cisplatin ototoxicity
düzenli u., OLGUN Y., ALTUN Z. S., Pamukoğlu A., bayrak f., AKTAŞ S., et al.
10th APSCI 2015, Beijing, China, 30 April - 03 May 2015, pp.1241
2015
2015The Effect Of Aceytl L Carnitine on DNA Damage Related Genes Induced by Radiation and Cisplatin Treatment in Cohlear Cells
ALTUN Z. S., OLGUN Y., Pamukoğlu A., Bayrak A., Duzenli U., ÇETİNAYAK H. O., et al.
10th Asian Pacific Symposium on Cohlear Implants and Related Sciences.(APSCI), Beijing, China, 30 April - 03 May 2015, pp.1241-1242
2015
2015Adölesan ve Genç Erişkin Yaşta Solid Tümör Tanılı Olgularımız
ÜNEK İ. T., DEMİR N., OFLAZOĞLU U., ATAĞ E., SEMİZ H. S., KAZAZ S. N., et al.
21. Ulusal Kanser Kongresi, Antalya, Turkey, 22 - 26 April 2015, (Summary Text)
2015
2015Nöroblastomda Mifamurtide Etkisinin İn vitro ve ExVivo Araştırılması
AKTAŞ S., ERÇETİN A. P., PAMUKOĞLU A., OLGUN H. N.
21. Ulusal Kanser Kongresi, Antalya, Turkey, 22 - 26 April 2015, pp.285
2015
2015The Protective Role of N Acetyl Csyteine Against Cisplatin and Radiotherapy Induced Ototoxicity Nrf2 and Target Genes
ALTUN Z. S., Pamukoğlu A., OLGUN Y., AKTAŞ S., ÇETİNAYAK H. O., KIRKIM G., et al.
EACR –Sponsored 3rd Anticancer Agent Development Congress, Turkey, 18 - 19 May 2015, pp.189
2014
2014Post-Transplant EBV-DNAemia, Related Diseases and Effect of Therapy in a Cohort of Pediatric Liver Recipients.
Arikan C., Doganay L., Olgun N., Yilmaz C., Zeytun M., Farajov R., et al.
Joint International Congress of ILTS, ELITA and LICAGE, London, Canada, 4 - 07 June 2014, vol.20, (Summary Text)
2014
2014Medullablastom Hücrelerinde Koruyucu Ajanların Sisplatin ve Radyoterapi ile İndüklenmiş Hücre Ölümüne Etkisi
PAMUKOĞLU KAYNAR A., ALTUN Z. S., Erçetin A., ÇETİNAYAK H. O., OLGUN Y., AKTAŞ S., et al.
XVIII. Ulusal Pediatrik Kanser Kongresi, Bodrum, Turkey, 13 - 17 May 2014, (Summary Text)
2014
2014Sanguinarine has in vitro less ototoxic effect than cisplatin
ÇEÇEN E., ERÇETİN P., KIRKIM G., PAMUKOĞLU A., AYÇA P., AKTAŞ S., et al.
EACR-Sponsored 2nd AnticancerAgents Congress:Targeting Cancer Stem Cells, Turkey, 1 - 03 April 2014, (Full Text)
2013
2013THE EFFECTS OF PROTECTIVE AGENTS AGAINST CISPLATIN AND RADIOTHERAPY INDUCED CELL DEATH
PAMUKOĞLU A., ALTUN Z. S., ERÇETİN A. P., ÇETİNAYAK H. O., OLGUN Y., AKTAŞ S., et al.
1ST CELL DEATH RESEARCH CONGRESS, 30 October - 03 November 2013, (Summary Text)
2013
2013High-Dose Chemotherapy and Autologous Stem Cell Transplantation In Patients With High-Risk Neuroblastoma : Results Of Turkish Pediatric Oncology Group-Neuroblastoma 2003 (TPOG-NBL 2003) Protocol
Aksoylar S., Varan A., Vergin C., Hazar V., Akici F., Dagdeviren A., et al.
55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 7 - 10 December 2013, vol.122, (Summary Text)
2013
2013Evaluation ofototoxicity in children with cancer who received cisplatin and or carboplatin duringtreatment
İNCE D., MUTAFOĞLU K., KIRKIM G., OLGUN Y., BÜKE E., ŞERBETÇİOĞLU M. B., et al.
Pediatric Blood & Cancer, Pediatric Blood & Cancer, 10 - 12 September 2013, (Full Text)
2012
2012Siklofosfamid metabolik yolağında yer alan enzimlerin (CYP2C9 CYP2C8, ALDH1A, ALDH3A1) polimorfik özellikleri
Amirfallah A., ÇALIBAŞI G., ELLİDOKUZ H., OLGUN H. N., BASKIN Y.
24.Ulusal Biyokimya Kongresi, Konya, Turkey, 25 - 28 September 2012, vol.37, pp.14, (Summary Text)
2011
2011The Effect of Resveratrol on Ara C Induced Cerebellar Toxicity
ÖREL B., MUTAFOĞLU K., CİLAKER MIÇILI S., BAĞRIYANIK H. A., KİRAY M., ALTUN Z. S., et al.
4th International Congress on Nutrition and Cancer, Antalya, Turkey, 19 - 23 October 2011, (Summary Text)
2011
2011Kanser Farkındalığını Arttırmaya Yönelik Eğitim Serileri.
OBUT A., ÖZDEMİR A. A., ÖZDAMAR A., DEMİR B., YILMAZ B., DURSUN H., et al.
V. Özel Çalışma Modülü (ÖÇM) Sempozyumu, İzmir, Turkey, 23 September 2011, (Summary Text)
2011
2011Effects of Resveratrol on Liver Toxicity in Cisplatin-induced Rats
Kolatan H. E., Yılmaz O., Kiray M., Altun Z. S., Aktaş S., Olgun A., et al.
3rd East Mediterranean International Council for Laboratory Animal Science Symposium and XV. ICLAS General Assembly, İstanbul, Turkey, 10 - 12 June 2011, pp.1, (Summary Text)
2010
2010Nöroblastomda P14ARF Metilasyonunun Minimal Rezidüel Hastalıktaki Rolü
Erbayraktar Z., Zadeoğluları Z., Aktaş S., Ellidokuz H., Kırkalı F. G., Olgun N.
X. Ulusal Klinik Biyokimya Kongresi, Muğla, Turkey, 9 - 11 April 2010, pp.1, (Summary Text)
2008
2008High-dose chemotherapy followed by autologous stem cell transplantation in patients with high-risk neuroblastoma. A report from the Turkish Pediatric Oncology Group Neuroblastoma 2003 (TPOG-NBL-2003) protocol
Aksoylar S., Gunes D., Kansoy S., Uenal E., Hazar V., Anak S., et al.
6th Meeting of the EBMT Paediatric Diseases Working Party/1st Meeting of the EBMT Paediatric Nurses, Poznan, Poland, 2 - 04 June 2008, vol.42, (Summary Text)
2006
2006The role of HGF/C-met signalling pathway on the non-small cell lung cancer
Gumustekin M., Sis B., Bulut G., Kargi A., Oztop I., Olgun N., et al.
31st Congress of the Federation-of-European-Biochemical-Societies (FEBS), İstanbul, Turkey, 24 - 29 June 2006, vol.273, pp.89, (Summary Text)
2005
2005Effects of acyclovir on nitric oxide and cell death in herpesvirus type 1 and 2 infected HEp 2 cells Clinical Microbiology and Infection Effects of acyclovir on nitric oxide and cell death in herpesvirus type 1 and 2 infected HEp 2 cells
BASKIN A. H., BASKIN Y., YAZICI Z., N O., ÖZKUL A.
15th European Congress of Clinical and Infectious Diseases, DANİMARKA, Nisan 2005, 2 - 05 April 2005, (Full Text)
1997
1997Pediatrik Nörofibromatosis 1 olgularında beyin MRG bulguları P 117
ERBAY G., ADA E., UYSAL K., ERBAY A., OLGUN H. N.
3.Tıbbi Görüntüleme ve Girişimsel Kongresi, Antalya, 28 ekim-2 Kasım 1997, Antalya, Turkey, 28 October - 02 November 1997
Books
2022
2022Kanser ve Beslenme (El Kitabı)
Arayıcı M. E., Çeçen R. E., Ellidokuz H., Olgun H. N.
Dokuz Eylül Yayınları, İzmir, 2022
2022
2022Çocuklarda Doğru Beslenme (El Kitabı)
Arayıcı M. E., Çeçen R. E., Ellidokuz H., Olgun H. N.
Dokuz Eylül Yayınları, İzmir, 2022
2022
2022Yüksek Grad Gliomların Tedavisinde Güncel Gelişmeler
İNCE D., ÇEÇEN R. E., OLGUN H. N.
in: Çocuk ve Ergenlerde Beyin Tümörleri: Güncel Yaklaşım - 2022, EMEL CABİ ÜNAL, Editor, TÜRKİYE KLİNİKLERİ, Ankara, pp.63-69, 2022
2022
202217 Hematoloji-Onkoloji / 14 Solid Tümörler
ÇEÇEN R. E., İNCE D., OLGUN H. N.
in: İZMİR DR BEHÇET UZ ÇOCUK HASTANESİ PEDİATRİ, Özkan B, Can D, Meşe T, Ünalp A, Ağın H, Devrim İ, Editor, Ankara Nobel Tıp Kitabevleri, İzmir, pp.1006-1017, 2022
2021
2021Molecular Heterogeneity in Neuroblastoma and Clinical Significance
Aktaş T. Ç., Aktaş S., Serinan E. Ö., Erçetin A. P., Aydın M., Gökbayrak Ö., et al.
in: 3. International Baku Scientific Research Congress, Prof Dr Gulzar Ibrahimova, Editor, Science Azerbaycan, Baku, pp.1171-1180, 2021
2021
2021Effect of MSCs on Cisplatin Toxicity in Neuroblastoma Model
Aktaş S., Olgun Y., Evin Eskicioğlu H., Erçetin A. P., Aktaş T. Ç., Yılmaz O., et al.
in: 3. International Baku Scientific Research Congress The Book of Full Text, Prof Dr Gulzar Ibrahimova, Editor, Science Azerbaycan, Baku, pp.801-816, 2021
2021
2021NÖROBLASTOM
ÇEÇEN R. E., İNCE D., OLGUN H. N.
in: TÜRKİYE KLİNİKLERİ ÇOCUKLUK ÇAĞINDA NADİR GÖRÜLEN TÜMÖRLER, EMEL CABİ ÜNAL, Editor, TÜRKİYE KLİNİKLERİ, pp.22-31, 2021
2021
2021Nöroblastoma
ÇEÇEN R. E., İNCE D., OLGUN H. N.
in: Türkiye Klinikleri Çocuk Hematolojisi ve Onkolojisi, Özel Konular, Çocukluk Çağında Nadir Görülen Tümörler, Emel Ünal Cabi, Editor, Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret AŞ, Ankara, pp.22-31, 2021
2017
2017Nöroblastom
ÇEÇEN R. E., OLGUN H. N.
in: Yurdakök Pediatri, Murat yurdakök, Editor, Güneş Kitabevi, pp.4230-4235, 2017
Funded Projects
2024 - Present
2024 - Present
SARSASAPOGENİNİN VE 5-FLUOROURASİL KOMBİNASYONUNUN KOLOREKTAL KANSERDEKİ POTANSİYEL ANTİTÜMORAL ETKİLERİNİN INVITRO VE INVIVO OLARAK İNCELENMESİ
Project Supported by Higher Education Institutions
KUMAŞ KULUALP M. (Executive), BARIŞ M. M., KUM ÖZŞENGEZER S., YURTAL Z., AKTAŞ T. Ç., BALBAL B., et al.
2023 - Present
2023 - Presentİzmir ilinin tıbbi jeolojik tehlike ve risklerinin belirlenmesine çok disiplinli bir yaklaşım İZTIPJEOL
Project Supported by Higher Education Institutions
ŞİMŞEK C. (Executive), HAJIALILOUYBONAB N., AKPINAR Y., TOKCAER M., TAŞKIN N., BOSTANCI K., et al.
2022 - Present
2022 - PresentPolieter İyonoforların Nöroblastomda Potansiyel Antikanser Etkilerinin İncelenmesi
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive), SANLAV G., ALTUN Z. S.
2023 - 2026
2023 - 2026
Çocukluk Çağı Kanserlerinde Genomik Profilleme Tabanlı Onkolojik Tedaviye Yönelik Biyobelirteç Geliştirilmesi
Project Supported by Higher Education Institutions
(Project Abstract)
Aktaş S., Özer E. (Executive), Altun Z. S., Olgun H. N., Serinan E., Aktaş T., et al.
2022 - 2024
2022 - 2024
Polieter İyonoforların Nöroblastomda Potansiyel Anti-kanser Etkilerinin İncelenmesi
Research Project of the Presidency of Turkey Health Institutes (TÜSEB)
Sanlav G.(Executive), Altun Z. S., Olgun H. N., Aktaş S., Bedir E., Yılmaz O.
2022 - 2024
2022 - 2024Nöroblastomda Hedeflenmiş Anti-Kanser İlaç Taşınımı
Association (NGO)
(Project Abstract)
Aktaş S. (Executive), Olgun H. N., Erol A., Gökbayrak Ö.
2021 - 2024
2021 - 2024Nöroblastom ve Hippo Sinyal Yolağı
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive), Kum Özşengezer S., YUAN H., ALTUN Z. S.
2021 - 2024
2021 - 2024
Nöroblastomda Kanser Kök Hücresi Hedefli Tedavilerin Geliştirilmesinde Biyoinformatik, Makine Öğrenmesi ve Hesapsal Kimya Temelli Bakış
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
2023 - 2023
2023 - 2023
Saglık Bilimlerinde Arastırma Projeleri Hazırlama Egitimi
TUBITAK Project
(Project Abstract)
Altun Z. S., Genç Ş. (Executive), Çavdar Z., Yılmaz O., Olgun H. N., Yılmaz M. B., et al.
2022 - 2023
2022 - 2023
Sisplatin ototoksisitesinde Gen Değişimi Düzeyinde Yeni Biyobelirteç Geliştirme
Association (NGO)
(Project Abstract)
(Project Final Report)
Kızmazoğlu D. (Executive), Aktaş S., Olgun Y., Altun Z. S., Demir A. B., Kırkım G., et al.
2022 - 2023
2022 - 2023İn vitro hipoksik nöroblastom modelinde metformin ve sisplatin kombinasyon tedavisinin hücre canlılığı üzerine etkisi
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive), BAYRAK S., BAYRAK Ö.
2021 - 2023
2021 - 2023SMAC mimetiklerinin Nöroblastom Hücreleri Üzerinde Apoptotik ve Nekropitotik Ölüm Mekanizmalarına Etkisi
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive), BARAN B.
2021 - 2022
2021 - 2022
Nöroblastom kök hücreleri ve Hippo Sinyal Yolağı
Association (NGO)
(Project Abstract)
Altun Z. S., Olgun H. N. (Executive), Kum Özşengezer S.
2020 - 2022
2020 - 2022
NÖROBLASTOMDA DİFERANSİASYON sürecinde etkili mikroRNA’lar ve HEDEFLERİ
Association (NGO)
(Project Abstract)
Altun Z. S. (Executive), Aktaş S., Kızmazoğlu D., Olgun H. N.
2019 - 2022
2019 - 2022Investigation of the potential of circulating cell-free and exosomal miRNA expression levels as non-invasive diagnostic biomarker in pediatric Burkitt lymphoma
TUBITAK Project
Küçük C.(Executive), Olgun H. N., Yuan H.
2018 - 2022
2018 - 2022Pediatrik Burkitt Lenfoma Hastalarında Dolaşımsal Serbest ve Ekzozomal MikroRNA İfade Seviyelerinin İnvazif Olmayan Tanı Biyobelirteci Olma Potansiyellerinin İncelenmesi.
TUBITAK Project
(Project Abstract)
Altun Z. S., Küçük C. (Executive), Olgun H. N., Çımrın D., Aktaş S., Özer E., et al.
2018 - 2022
2018 - 2022Eksozomal biyobelirteçlerin Nöroblastomun Moleküler ve Klinik Önemine Katkısı
Association (NGO)
(Project Abstract)
Altun Z. S. (Executive), Olgun H. N., Aktaş S.
2019 - 2021
2019 - 2021
Kanserde heterojenitenin Klinik Önemi
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
2018 - 2021
2018 - 2021
Caulerpa cylindracea türünden caulerpinin kolorektal kanser hücreleri üzerine biyolojik etkisi
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
2018 - 2021
2018 - 2021
LCIF Mathcing Grant Childhood Cancer Project
Project Supported by Private Organizations in Other Countries
(Project Abstract)
Aktaş S. (Executive), Olgun H. N.
2018 - 2020
2018 - 2020
KEMİK KANSERLERİNDE KULLANILAN KEMO-İMMUNOTERAPİNİN VE GREFT MATERYALLERİNİN MİKROÇEVRE İLİŞKİSİ
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
2018 - 2019
2018 - 2019NÖROBLASTOMDA MOLEKÜLER HETEROJENİTE VE KLİNİK ÖNEMİ
Project Supported by Other Private Institutions
AKTAŞ S., ALTUN Z. S., OLGUN H. N. (Executive)
2018 - 2019
2018 - 2019
Kemik kanserlerinde kullanılan kemoimmunoterapinin ve greft materyallerinin mikroçevre ile ilişkisi
Project Supported by Other Private Institutions
YILMAZ O., OLGUN H. N., KOLATAN H. E., AKTAŞ S. (Executive)
2017 - 2018
2017 - 2018N?roblastom 3D Modelllerinde normoksik/hipoksik mikro?evrenin hipoksia-1 alpha ?zerinden reg?le edilen h?cre mekanizmalar?na olan etkisi; Metabolamik yakla??m
Project Supported by Higher Education Institutions
Ellidokuz H., Çalıbaşı Koçal G., , Başbınar Y., Uysal Kılıç T., Olgun H. N. (Executive)
2017 - 2018
2017 - 2018Nöroblastom 3D Modelllerinde normoksik/hipoksik mikroçevrenin hipoksia-1 alpha üzerinden regüle edilen hücre mekanizmalarına olan etkisi; Metabolamik yaklaşım
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
2017 - 2018
2017 - 2018Effect of normoxic/hypoxic microenvironment on cell mechanisms regulated by hypoxia-1 alpha in neuroblastoma 3D models - Metabolomic approach
Project Supported by Higher Education Institutions
Çalıbaşı Koçal G., Olgun H. N. (Executive), Başbınar Y.
2017 - 2017
2017 - 2017Oleuropein ve Sisplatinin Nöroblastom Hücreleri Üzerine Etkisi
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
2014 - 2017
2014 - 2017
PANKREAS KANSERİNDE ELONGASYON İNİSİASYON FAKTÖR 2 ALFA İLE SUSUTURULMASI SONRASINDA HÜCRE ÜLÜMÜNÜN ARAŞTIRILMASI
TUBITAK Project
AKTAŞ S., OLGUN H. N.
2014 - 2017
2014 - 2017Türkiye Populasyonunda Çocukluk Çağı Solid Tümörlerinin Sağaltımında Kullanılan İlaçları Metabolize Eden Enzim Polimorfizmleri ve Hastalığın Etkin Yönetiminde Yardımcı Ulusal Protokollerin Geliştirilmesi
Project Supported by Higher Education Institutions
Olgun H. N., Ellidokuz H. (Executive)
2015 - 2016
2015 - 2016Nöroblastom Moleküler Temelinin Klinik Öneminin Arastırılması Proteomik yaklaşım
Project Supported by Other Private Institutions
OLGUN H. N., AKTAŞ S.
2015 - 2016
2015 - 2016Hepatoblastomların moleküler sınıflandırılması ve klinik önemi
Project Supported by Higher Education Institutions
ERÇETİN A. P., AKTAŞ S., OLGUN H. N. (Executive)
2013 - 2016
2013 - 2016Nöroblastom hücrelerinde adiposit kökenli kök hücre ortamının kök hücre belirteçleri ve diferansiasyon üzerine etkisi
Project Supported by Higher Education Institutions
ERÇETİN A. P., AKTAŞ S., OLGUN H. N. (Executive)
2014 - 2015
2014 - 2015Nöroblastomda Prognostik Genetik Belirteçlerin Klinik Evrelere Göre Önemi
Project Supported by Higher Education Institutions
OLGUN H. N., AKTAŞ S., ALTUN Z. S. (Executive), DEMİR A. B.
2013 - 2015
2013 - 2015Asetil L Karnitin ve N Asetil Sisteinin House Ear Instıtute Organ Corti 1 HEI OC1 Ve İnsan Medulloblastom Hücreleri Üzerinde Sisplatin Ve Radyasyon Toksisitesi Üzerine Etkileri
Project Supported by Higher Education Institutions
ÇETİNAYAK H. O., OLGUN H. N., ATEŞ H., AKTAŞ S., ALTUN Z. S. (Executive), KIRKIM G., et al.
2013 - 2015
2013 - 2015PEDİATRİK VE ERİŞKİN HODGKİN LENFOMALARDA MİKRORNA EKSPRESYON FARKLILIĞI
Project Supported by Higher Education Institutions
AKTAŞ S., OLGUN H. N. (Executive)
2012 - 2013
2012 - 2013Nörofibromatozis Tip 1 Olgularında DNA Tamir Genlerinin Ekspresyonunun Klinik Önemi
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
2012 - 2013
2012 - 2013NÖROBLASTOM MİKRORNA İLİŞKİSİ
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
2011 - 2013
2011 - 2013ASETİL L–KARNİTİNİN, DENEYSEL DOKSORUBİSİN KARDİYOTOKSİSİTESİ ÜZERİNE ETKİLERİNİN ARAŞTIRILMASI
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
2010 - 2011
2010 - 2011Wilms Tümöründe Mikrosatellit İnstabilite (Msi) Varlığı Ve Dna Onarım Genlerinden Mlh1, Msh2, Msh6, Pms2’nin Doku Ekspresyon Düzeyindeki Değişimler
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
2008 - 2011
2008 - 2011Fitokimyasal Maddelerin Nöroblastom ve Metastaz Potansiyeli Üzerine Etkisi
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
2007 - 2010
2007 - 2010L-KARNİTİN UYGULAMASININ SİSPLATİN TOKSİSİTESİ ÜZERİNE ETKİSİNİN DEĞERLENDİRİLMESİ
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
2005 - 2008
2005 - 2008Sitostatik, Diferansiye Edici ve Apoptotik Ajanların Nöroblastom Hücrelerinde N- myc’in Ultrastrüktürel Lokalizasyonuna Etkisi
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
2005 - 2007
2005 - 2007Epstein Barr Virüs Pozitif ve Negatif Pediatrik Hodgkin ve nonHodgkin Lenfomalarda Hücre Proliferasyonu ve Apoptotik İlişkili Faktörlerin Prognoz ile İlişkisi
Project Supported by Higher Education Institutions
OLGUN H. N. (Executive)
Roles in Event Organizations
Ekim 2022
Ekim 2022Nöroblastom 2022 Sempozyumu
Scientific Congress
Kızmazoğlu D., OLGUN H. N., ÇEÇEN R. E.
İzmir, Turkey
Awards
March 2023
March 2023Sözel Bildiri Birincilik Ödülü
22. Ulusal Pediatrik Kanser Kongresi
March 2023
March 2023
Sözlü Bildiri 3.lük Ödülü- Sisplatin ototoksisitesinde gen değişimi düzeyinde yeni biyobelirteç geliştirme
Türk Pediatrik Onkoloji Grubu- Tpog
November 2022
November 2022Prof. Dr. Nebil Büyükpamukçu Ödülü- Pediatrik nöroblastik tümörlerde görüntülemeye dayalı risk faktörlerinin (IDRF) belirleyiciliği
39. Ulusal Çocuk Cerrahisi Kongresi
March 2022
March 2022
3rd Poster Prize-The effect of SMAC mimetic on apoptotic gene expressions
4Hh Congress Of Cell Death Research Society Turkiye-With International Participation
November 2021
November 2021Sözlü Bildiri Üçüncülük Ödülü
Tpog
April 2021
April 2021Türk Pediatrik Onkoloji Grubu Derneği- Proje ödülü 2021
Türk Pediatrik Onkoloji Grubu Derneği- Tpog
Congress and Symposium Activities
26 May 2023 - 26 May 2023
26 May 2023 - 26 May 2023